Striatal cholinergic interneuron regulation and circuit effects
The striatum plays a central role in motor control and motor learning. Appropriate responses to environmental stimuli, including pursuit of reward or avoidance of aversive experience all require functional striatal circuits. These pathways integrate synaptic inputs from limbic and cortical regions i...
Saved in:
| Published in | Frontiers in synaptic neuroscience Vol. 6; p. 22 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
Switzerland
Frontiers Media S.A
21.10.2014
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1663-3563 1663-3563 |
| DOI | 10.3389/fnsyn.2014.00022 |
Cover
| Abstract | The striatum plays a central role in motor control and motor learning. Appropriate responses to environmental stimuli, including pursuit of reward or avoidance of aversive experience all require functional striatal circuits. These pathways integrate synaptic inputs from limbic and cortical regions including sensory, motor and motivational information to ultimately connect intention to action. Although many neurotransmitters participate in striatal circuitry, one critically important player is acetylcholine (ACh). Relative to other brain areas, the striatum contains exceptionally high levels of ACh, the enzymes that catalyze its synthesis and breakdown, as well as both nicotinic and muscarinic receptor types that mediate its postsynaptic effects. The principal source of striatal ACh is the cholinergic interneuron (ChI), which comprises only about 1-2% of all striatal cells yet sends dense arbors of projections throughout the striatum. This review summarizes recent advances in our understanding of the factors affecting the excitability of these neurons through acute effects and long term changes in their synaptic inputs. In addition, we discuss the physiological effects of ACh in the striatum, and how changes in ACh levels may contribute to disease states during striatal dysfunction. |
|---|---|
| AbstractList | The striatum plays a central role in motor control and motor learning. Appropriate responses to environmental stimuli, including pursuit of reward or avoidance of aversive experience all require functional striatal circuits. These pathways integrate synaptic inputs from limbic and cortical regions including sensory, motor and motivational information to ultimately connect intention to action. Although many neurotransmitters participate in striatal circuitry, one critically important player is acetylcholine (ACh). Relative to other brain areas, the striatum contains exceptionally high levels of ACh, the enzymes that catalyze its synthesis and breakdown, as well as both nicotinic and muscarinic receptor types that mediate its postsynaptic effects. The principal source of striatal ACh is the cholinergic interneuron (ChI), which comprises only about 1-2% of all striatal cells yet sends dense arbors of projections throughout the striatum. This review summarizes recent advances in our understanding of the factors affecting the excitability of these neurons through acute effects and long term changes in their synaptic inputs. In addition, we discuss the physiological effects of ACh in the striatum, and how changes in ACh levels may contribute to disease states during striatal dysfunction. The striatum plays a central role in motor control and motor learning. Appropriate responses to environmental stimuli, including pursuit of reward or avoidance of aversive experience all require functional striatal circuits. These pathways integrate synaptic inputs from limbic and cortical regions including sensory, motor and motivational information to ultimately connect intention to action. Although many neurotransmitters participate in striatal circuitry, one critically important player is acetylcholine (ACh). Relative to other brain areas, the striatum contains exceptionally high levels of ACh, the enzymes that catalyze its synthesis and breakdown, as well as both nicotinic and muscarinic receptor types that mediate its postsynaptic effects. The principal source of striatal ACh is the cholinergic interneuron (ChI), which comprises only about 1-2% of all striatal cells yet sends dense arbors of projections throughout the striatum. This review summarizes recent advances in our understanding of the factors affecting the excitability of these neurons through acute effects and long term changes in their synaptic inputs. In addition, we discuss the physiological effects of ACh in the striatum, and how changes in ACh levels may contribute to disease states during striatal dysfunction.The striatum plays a central role in motor control and motor learning. Appropriate responses to environmental stimuli, including pursuit of reward or avoidance of aversive experience all require functional striatal circuits. These pathways integrate synaptic inputs from limbic and cortical regions including sensory, motor and motivational information to ultimately connect intention to action. Although many neurotransmitters participate in striatal circuitry, one critically important player is acetylcholine (ACh). Relative to other brain areas, the striatum contains exceptionally high levels of ACh, the enzymes that catalyze its synthesis and breakdown, as well as both nicotinic and muscarinic receptor types that mediate its postsynaptic effects. The principal source of striatal ACh is the cholinergic interneuron (ChI), which comprises only about 1-2% of all striatal cells yet sends dense arbors of projections throughout the striatum. This review summarizes recent advances in our understanding of the factors affecting the excitability of these neurons through acute effects and long term changes in their synaptic inputs. In addition, we discuss the physiological effects of ACh in the striatum, and how changes in ACh levels may contribute to disease states during striatal dysfunction. |
| Author | Lim, Sean Austin O. McGehee, Daniel S. Kang, Un Jung |
| AuthorAffiliation | 2 Department of Neurology, Columbia University New York, NY, USA 3 Department of Anesthesia and Critical Care, University of Chicago Chicago, IL, USA 1 Committee on Neurobiology, University of Chicago Chicago, IL, USA |
| AuthorAffiliation_xml | – name: 1 Committee on Neurobiology, University of Chicago Chicago, IL, USA – name: 3 Department of Anesthesia and Critical Care, University of Chicago Chicago, IL, USA – name: 2 Department of Neurology, Columbia University New York, NY, USA |
| Author_xml | – sequence: 1 givenname: Sean Austin O. surname: Lim fullname: Lim, Sean Austin O. – sequence: 2 givenname: Un Jung surname: Kang fullname: Kang, Un Jung – sequence: 3 givenname: Daniel S. surname: McGehee fullname: McGehee, Daniel S. |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25374536$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kc1rFTEUxYNUbH1270pm6ea95nuSjSJFbaHgQl2HO5mb15R5SU0yQv97p--10gqucsk953fgntfkKOWEhLxldCOEsWch1bu04ZTJDaWU8xfkhGkt1kJpcfRkPiantd4sEiopp1S8IsdciV4qoU_Ix--tRGgwdf46TzFh2UbfxdSwJJxLTl3B7TxBi8sIaex8LH6OrcMQ0Lf6hrwMMFU8fXhX5OeXzz_OL9ZX375enn-6WnspBV8PJgDjekQwOEijPfNAB_BKKTN6NgawweIQemYHtJYq2VsMmgLC0IdxECtyeeCOGW7cbYk7KHcuQ3T7j1y2DkqLfkLHUPfK0B6t55Jza9QAwuugBHBGeb-wPhxYt_Oww9FjagWmZ9DnmxSv3Tb_dpJTKZe7rcj7B0DJv2asze1i9ThNkDDP1THNOVVGcLNI3z3N-hvy2MAi0AeBL7nWgsH52PbnXqLj5Bh19227fdvuvm23b3sx0n-Mj-z_Wv4AKNevbQ |
| CitedBy_id | crossref_primary_10_1016_j_bbr_2016_06_022 crossref_primary_10_1152_physrev_00014_2018 crossref_primary_10_1002_cne_24279 crossref_primary_10_1016_j_biopsych_2024_10_005 crossref_primary_10_1523_JNEUROSCI_0730_15_2015 crossref_primary_10_3389_fnmol_2023_1098211 crossref_primary_10_1016_j_expneurol_2021_113670 crossref_primary_10_1038_s41380_021_01112_2 crossref_primary_10_1523_JNEUROSCI_1627_21_2022 crossref_primary_10_1186_s13578_024_01328_z crossref_primary_10_1016_j_nbd_2017_10_010 crossref_primary_10_1016_j_pneurobio_2015_07_002 crossref_primary_10_3390_ijms22094299 crossref_primary_10_1038_s41467_024_46088_z crossref_primary_10_1186_s12883_024_03578_3 crossref_primary_10_1016_j_bbi_2017_12_004 crossref_primary_10_1016_j_tins_2017_05_004 crossref_primary_10_1111_ejn_15074 crossref_primary_10_7554_eLife_39786 crossref_primary_10_1093_ijnp_pyw021 crossref_primary_10_1016_j_nbd_2016_02_019 crossref_primary_10_3389_fnins_2018_01023 crossref_primary_10_1007_s11071_019_05249_2 crossref_primary_10_1016_j_celrep_2023_112783 crossref_primary_10_3389_fnmol_2024_1383963 crossref_primary_10_1007_s00702_018_1845_9 crossref_primary_10_1021_acschemneuro_7b00398 crossref_primary_10_1093_ntr_nty063 crossref_primary_10_1016_j_biopha_2024_117145 crossref_primary_10_1016_j_bbr_2016_10_016 crossref_primary_10_3389_fncir_2021_724858 crossref_primary_10_3389_fnins_2021_665820 crossref_primary_10_1016_j_nlm_2018_06_008 crossref_primary_10_1002_brb3_2511 crossref_primary_10_1016_j_biopsych_2020_08_022 crossref_primary_10_1126_scisignal_ado9852 crossref_primary_10_3390_nu11112731 crossref_primary_10_7554_eLife_44903 crossref_primary_10_1016_j_neuron_2019_05_031 crossref_primary_10_1111_ejn_13462 crossref_primary_10_1016_j_nbd_2015_12_010 crossref_primary_10_1111_ejn_14153 crossref_primary_10_1016_j_celrep_2020_107527 crossref_primary_10_1016_j_celrep_2021_108718 crossref_primary_10_1016_j_ibneur_2021_05_003 crossref_primary_10_1002_syn_22081 crossref_primary_10_1177_0271678X221142533 crossref_primary_10_1126_sciadv_adn2446 crossref_primary_10_1002_cne_24013 crossref_primary_10_1111_ejn_13638 crossref_primary_10_1523_ENEURO_0277_19_2019 crossref_primary_10_1016_j_parkreldis_2019_02_017 crossref_primary_10_1016_j_neurol_2018_07_003 crossref_primary_10_1016_j_expneurol_2019_01_019 crossref_primary_10_1016_j_biopsych_2019_02_014 crossref_primary_10_1177_0269881120944156 crossref_primary_10_1111_jnc_15034 crossref_primary_10_1016_j_bmcl_2021_128206 crossref_primary_10_1172_JCI154969 crossref_primary_10_1038_npp_2016_81 crossref_primary_10_3389_fendo_2022_993552 crossref_primary_10_1038_s42003_021_02567_3 crossref_primary_10_3389_fnagi_2020_00004 crossref_primary_10_1111_jnc_15555 crossref_primary_10_1016_j_neuron_2019_06_013 crossref_primary_10_1111_jnc_14105 crossref_primary_10_1038_s41467_020_15514_3 crossref_primary_10_1111_jnc_14919 crossref_primary_10_1038_s41398_023_02306_8 crossref_primary_10_1016_j_dscb_2022_100054 crossref_primary_10_1038_s41467_022_35601_x crossref_primary_10_1016_j_phrs_2024_107190 crossref_primary_10_1080_14789450_2023_2265067 crossref_primary_10_17650_2222_8721_2020_10_3_10_26 crossref_primary_10_1016_j_celrep_2018_11_053 crossref_primary_10_1016_j_neuron_2016_06_021 crossref_primary_10_2217_pgs_2019_0100 crossref_primary_10_1002_ana_26805 crossref_primary_10_3389_fnmol_2022_991732 crossref_primary_10_1016_j_bbi_2024_07_044 crossref_primary_10_1523_ENEURO_0196_21_2021 crossref_primary_10_1176_appi_ajp_2020_19070698 crossref_primary_10_3389_fnsyn_2015_00014 crossref_primary_10_1016_j_isci_2020_101330 crossref_primary_10_1016_j_nbd_2023_106360 crossref_primary_10_1111_jnc_16264 crossref_primary_10_1080_15622975_2018_1548780 crossref_primary_10_1007_s12035_020_02201_z crossref_primary_10_3389_fnmol_2024_1451010 crossref_primary_10_3390_brainsci10120903 crossref_primary_10_3389_fnana_2016_00001 crossref_primary_10_1111_jnc_14003 crossref_primary_10_1073_pnas_1901712116 crossref_primary_10_1016_j_neuron_2018_12_004 crossref_primary_10_1111_ejn_13949 crossref_primary_10_1177_2045125320937575 crossref_primary_10_1016_j_biopsych_2019_11_001 crossref_primary_10_3390_cells10040907 crossref_primary_10_3390_ijms24021685 crossref_primary_10_1007_s12565_018_0457_7 crossref_primary_10_1016_j_nbd_2024_106774 crossref_primary_10_1016_j_neuron_2022_07_011 crossref_primary_10_1016_j_ynirp_2025_100234 crossref_primary_10_1111_ejn_14873 crossref_primary_10_1002_jnr_24668 crossref_primary_10_3390_cells10030709 crossref_primary_10_1016_j_preteyeres_2019_06_003 crossref_primary_10_1080_14656566_2016_1254189 crossref_primary_10_1192_bja_2018_46 crossref_primary_10_5937_mckg51_15877 crossref_primary_10_3389_fnbeh_2017_00119 crossref_primary_10_1038_s41598_018_20271_x crossref_primary_10_3389_dyst_2022_10557 crossref_primary_10_1016_j_celrep_2023_112204 crossref_primary_10_1096_fj_202101425R crossref_primary_10_3389_fncel_2024_1415015 crossref_primary_10_1016_j_celrep_2019_06_077 crossref_primary_10_1111_nyas_12762 crossref_primary_10_1002_jnr_24110 crossref_primary_10_3390_molecules26082258 crossref_primary_10_1016_j_neures_2019_12_001 crossref_primary_10_1038_s41380_022_01643_2 crossref_primary_10_1016_j_bbr_2017_11_027 crossref_primary_10_1016_j_neuropharm_2017_01_020 crossref_primary_10_1111_jnc_14701 crossref_primary_10_1155_2015_472676 crossref_primary_10_3389_fnsys_2020_626412 crossref_primary_10_4103_1673_5374_382987 crossref_primary_10_1016_j_neuroscience_2021_05_026 crossref_primary_10_1007_s00702_017_1803_y crossref_primary_10_1016_j_neubiorev_2019_12_007 crossref_primary_10_3390_ijms19051392 crossref_primary_10_1016_j_neubiorev_2017_09_003 crossref_primary_10_1111_ejn_13726 crossref_primary_10_3389_fncel_2022_1010121 crossref_primary_10_9758_cpn_2018_16_2_224 crossref_primary_10_1016_j_talanta_2022_123965 crossref_primary_10_3389_fnmol_2019_00211 crossref_primary_10_3390_biomedicines12122865 crossref_primary_10_3389_fnmol_2019_00204 crossref_primary_10_1016_j_neuropharm_2022_109027 crossref_primary_10_7554_eLife_40202 crossref_primary_10_1523_JNEUROSCI_0967_20_2021 crossref_primary_10_3389_fncir_2021_665386 crossref_primary_10_3390_biomedicines10010101 crossref_primary_10_1016_j_neuint_2019_02_019 crossref_primary_10_1016_j_celrep_2022_110874 crossref_primary_10_1523_ENEURO_0386_18_2018 crossref_primary_10_7554_eLife_35657 |
| Cites_doi | 10.1111/j.1460-9568.2004.03576.x 10.1111/ejn.12160 10.1016/0896-6273(91)90076-C 10.1176/ajp.155.11.1490 10.1016/j.expneurol.2008.11.001 10.1089/cap.2000.10.59 10.1016/j.biopsych.2013.04.004 10.1016/j.physbeh.2006.05.024 10.1038/nature09159 10.1523/JNEUROSCI.2888-13.2014 10.1523/JNEUROSCI.18-14-05180.1998 10.1038/nature11657 10.1101/lm.82104 10.1006/mcne.2002.1202 10.1097/01.wnr.0000081861.45938.71 10.1111/j.1471-4159.1990.tb08817.x 10.1523/JNEUROSCI.2939-09.2009 10.1007/s11011-013-9417-z 10.1016/0306-4522(96)00066-8 10.1038/nn769 10.1002/mds.20700 10.1523/JNEUROSCI.5620-09.2010 10.1016/0006-8993(92)90830-3 10.1016/j.neubiorev.2003.11.015 10.1002/cne.1186 10.1016/S0306-4522(00)00071-3 10.1016/0014-2999(89)90446-9 10.3389/fnsys.2012.00033 10.1523/JNEUROSCI.5996-09.2010 10.1016/j.clinthera.2008.01.010 10.1016/S0896-6273(01)00516-5 10.1016/0006-8993(76)90583-7 10.1007/s00213-013-3116-7 10.1007/BF00568893 10.1007/978-94-007-4765-4_13 10.1523/JNEUROSCI.13-11-04908.1993 10.1007/BF01959461 10.1016/0361-9230(81)90004-6 10.1523/JNEUROSCI.3709-06.2007 10.1007/s10072-011-0816-9 10.2174/156802610790410983 10.1038/379449a0 10.1124/jpet.113.211532 10.1002/cne.902490302 10.1017/S1462399409001148 10.1016/S0166-4328(00)00210-2 10.1111/j.1460-9568.2005.04154.x 10.1124/mol.63.5.1169 10.1038/sj.bjp.0706440 10.1016/S0079-6123(08)62387-0 10.1016/S0306-4522(03)00220-3 10.1016/S0022-3565(25)13124-8 10.1002/mds.1090 10.1111/ejn.12298 10.1002/mds.25028 10.1111/j.1471-4159.1985.tb04029.x 10.1016/S0028-3908(00)00131-3 10.1038/383713a0 10.1038/sj.bjp.0705916 10.1016/0304-3940(89)90130-4 10.1016/0006-8993(91)90554-9 10.1016/j.pneurobio.2004.02.004 10.1006/exnr.1999.7092 10.1016/j.jchemneu.2007.02.008 10.1523/JNEUROSCI.23-12-05272.2003 10.1038/ng.487 10.1016/S0306-4522(98)00527-2 10.1515/revneuro-2012-0063 10.1016/j.pneurobio.2006.11.001 10.1016/0306-4522(92)90401-M 10.3233/BEN-129025 10.1016/0304-3940(87)90298-9 10.1016/0306-4522(95)00010-G 10.1016/j.jchemneu.2004.08.007 10.1523/JNEUROSCI.12-09-03591.1992 10.1016/0006-8993(86)90629-3 10.1152/jn.1998.79.5.2568 10.1038/sj.mp.4001257 10.1016/j.tins.2006.12.003 10.1007/PL00004917 10.1523/JNEUROSCI.07-12-03915.1987 10.1016/0306-4522(95)00507-2 10.1152/jn.00760.2007 10.1016/S0306-4522(99)00440-6 10.1016/j.tips.2006.07.004 10.1016/j.brainres.2011.01.026 10.1523/JNEUROSCI.14-05-03351.1994 10.1523/JNEUROSCI.15-01-00458.1995 10.1016/S0891-0618(03)00002-4 10.1046/j.0953-816x.2001.01783.x 10.1111/jnc.12442 10.1152/jn.00853.2004 10.1016/j.neulet.2004.02.068 10.1073/pnas.1006511108 10.1152/physrev.00036.2003 10.1523/JNEUROSCI.21-05-01452.2001 10.1016/0006-8993(74)90700-8 10.1212/WNL.0b013e3181dc1a55 10.1038/nn.3048 10.1523/JNEUROSCI.1754-10.2010 10.1046/j.0022-3042.2002.00805.x 10.1038/sj.npp.1301294 10.1152/jn.00305.2011 10.1016/0306-4522(91)90344-N 10.1016/0006-8993(81)90211-0 10.1002/ana.410430506 10.1212/WNL.0b013e3181f6128c 10.1016/0006-8993(82)91147-7 10.1124/mol.112.083352 10.1016/j.tins.2007.03.008 10.1046/j.1460-9568.2002.02289.x 10.1523/JNEUROSCI.15-12-07821.1995 10.1046/j.0953-816x.2001.01592.x 10.1523/JNEUROSCI.08-10-03750.1988 10.1007/s00213-012-2712-2 10.1007/PL00005773 10.1016/0361-9230(88)90244-4 10.1016/0361-9230(84)90236-3 10.1016/S0306-4522(99)00279-1 10.1523/JNEUROSCI.3225-04.2004 10.1038/308278a0 10.1523/JNEUROSCI.17-01-00204.1997 10.1523/JNEUROSCI.15-07-05297.1995 10.1212/WNL.47.2.557 10.1016/j.expneurol.2004.10.004 10.1001/archpsyc.59.12.1085 10.1016/j.pbb.2003.08.015 10.1097/YPG.0b013e32833a9b7a 10.1002/cne.902990206 10.1523/JNEUROSCI.18-23-10207.1998 10.1016/S0006-3223(00)01011-8 10.1523/JNEUROSCI.10-02-00508.1990 10.1080/09652140050111681 10.1016/j.nbd.2005.10.009 10.1007/s002109900098 10.1016/0304-3940(90)90099-U 10.1111/j.1471-4159.1993.tb05838.x 10.1113/jphysiol.1986.sp016304 10.1126/science.7569895 10.1038/nn1243 10.1093/brain/97.1.457 10.1001/archneur.63.5.782 10.1016/S1471-1931(00)00023-9 10.1016/j.celrep.2012.05.011 10.1371/journal.pone.0019155 10.1523/JNEUROSCI.0901-14.2014 10.1111/j.1469-7793.1998.441bk.x 10.1523/JNEUROSCI.04-11-02866.1984 10.1038/nn1700 10.1523/JNEUROSCI.17-02-00819.1997 10.1016/S0006-8993(97)01141-4 10.1113/jphysiol.2007.144501 10.1016/j.neuropharm.2013.07.006 10.1007/s00401-007-0316-4 10.1523/JNEUROSCI.2411-08.2008 10.1523/JNEUROSCI.2780-08.2008 10.1523/JNEUROSCI.5071-13.2014 10.1016/0006-8993(93)91459-6 10.1523/JNEUROSCI.4275-07.2008 10.3389/fnsys.2011.00011 10.1523/JNEUROSCI.16-16-05141.1996 10.1523/JNEUROSCI.21-04-01393.2001 10.1016/0361-9230(90)90186-4 10.1046/j.1471-4159.1994.62010070.x 10.1523/JNEUROSCI.17-15-05747.1997 10.1046/j.1440-1681.2003.03835.x 10.1016/0006-8993(87)90167-3 10.1111/j.1471-4159.1992.tb09752.x 10.1523/JNEUROSCI.22-15-06347.2002 10.1126/science.275.5297.213 10.1124/jpet.105.094375 10.1038/189123a0 10.1016/S0006-8993(00)02636-6 10.1124/jpet.102.039347 10.1007/s12402-009-0003-5 10.1016/j.neuroscience.2010.03.062 10.1016/0306-4522(94)90464-2 10.1007/BF02230432 10.1016/j.expneurol.2013.02.009 10.1002/cne.22206 10.1002/mds.20360 10.1016/j.neuron.2013.12.027 10.1016/j.nlm.2011.06.002 10.1007/s002109900097 10.1124/jpet.112.194084 10.1523/JNEUROSCI.14-05-03005.1994 10.1124/jpet.109.162396 10.1523/JNEUROSCI.19-09-03629.1999 10.1002/jcb.22270 10.1242/jeb.124.1.203 10.1016/S0028-3908(00)00184-2 10.1113/jphysiol.2005.098269 10.1016/S0028-3908(00)00102-7 10.3389/fnana.2010.00150 10.1016/S0306-4522(01)00039-2 10.1016/j.tins.2004.06.006 10.1016/S0026-895X(25)13594-3 10.1001/archpsyc.1977.01770230061003 10.1212/WNL.41.2_Part_1.202 10.1152/jn.1997.77.2.1003 10.1073/pnas.81.15.4998 10.1111/j.1601-183X.2007.00325.x 10.1124/jpet.113.207639 10.1113/jphysiol.2012.241786 10.1038/sj.bjp.0701394 10.1002/cne.23295 10.1016/S1074-7427(03)00077-7 10.1038/nn1244 10.1146/annurev.neuro.22.1.443 10.1101/cshperspect.a008862 10.1016/S0028-3908(00)00145-3 10.1002/(SICI)1096-9861(19990322)405:4<450::AID-CNE2>3.0.CO;2-# 10.1093/hmg/ddl252 10.1002/mds.21475 10.1016/0006-8993(76)90502-3 10.1152/physrev.00043.2007 10.2174/138161210790170166 10.1016/0306-4522(92)90057-9 10.1016/j.biopsycho.2006.01.005 10.1016/0306-4522(84)90165-9 10.1038/nrn1763 10.1016/j.neuron.2012.04.038 10.1038/npp.2012.194 10.1016/0024-3205(88)90492-4 10.1523/JNEUROSCI.0551-07.2007 10.1046/j.1460-9568.2000.00175.x 10.1016/S0072-9752(08)02133-7 10.1113/jphysiol.1941.sp003913 10.1111/j.1476-5381.1991.tb12203.x 10.1002/mds.870090618 10.1046/j.1471-4159.1997.68051942.x 10.1016/0006-8993(91)90810-I 10.1615/CritRevNeurobiol.v10.i1.40 10.1016/S0169-328X(98)00293-9 10.1523/JNEUROSCI.5535-06.2007 10.1007/BF02532375 10.1523/JNEUROSCI.21-17-06492.2001 10.1113/jphysiol.1910.sp001406 10.1016/S0306-4522(98)00681-2 10.1016/S0022-3565(25)12831-0 10.1016/j.biopsych.2013.06.002 10.1016/0306-4522(92)90293-B 10.1002/14651858.CD003735 10.1073/pnas.88.6.2608 10.1002/syn.1089 10.1038/35046067 10.1016/0166-4328(94)90149-X 10.2174/1568007023339210 10.1002/cne.23583 10.1016/0006-8993(75)90384-4 10.1111/j.1460-9568.1996.tb01206.x 10.1046/j.1471-4159.2002.00815.x 10.1002/cne.903500307 10.1523/JNEUROSCI.1381-05.2005 10.1016/j.bcp.2007.07.002 10.1016/j.expneurol.2014.03.001 10.1124/pr.110.003269 10.1016/j.nbd.2006.04.005 10.1152/jn.00148.2006 10.1124/pr.110.002642 10.1016/j.neuroscience.2014.01.010 10.1038/nature11466 10.2165/00002512-200017030-00002 10.1016/S0014-2999(00)00005-4 10.1016/0006-8993(92)91132-X 10.1523/JNEUROSCI.20-08-02783.2000 10.1523/JNEUROSCI.1778-09.2010 10.1111/j.1749-6632.1992.tb25966.x 10.1523/JNEUROSCI.3989-10.2010 10.1046/j.1471-4159.2000.740839.x 10.1523/JNEUROSCI.3572-12.2013 10.1002/mds.870080417 10.1523/JNEUROSCI.4029-08.2009 10.1016/j.cub.2011.05.001 10.1007/BF00169150 10.1176/appi.ajp.160.1.118 10.1111/j.1471-4159.1988.tb10580.x 10.1002/cne.1345 10.1016/0006-8993(90)91633-R 10.1152/jn.00422.2013 10.1016/0304-3940(90)90064-G 10.1038/sj.bjp.0703692 10.3389/fnana.2010.00131 10.1002/cne.903260204 10.1002/mds.25420 10.1073/pnas.87.18.7050 10.1016/j.ejphar.2009.04.058 10.1056/NEJM197606102942402 10.1155/2004/516302 10.1016/j.neurobiolaging.2014.03.014 10.1523/JNEUROSCI.17-06-01940.1997 10.3233/JPD-130204 10.3949/ccjm.78gr.11005 10.1038/nn2052 10.1111/j.1600-0404.1974.tb02820.x 10.1016/0014-2999(87)90533-4 10.1016/0896-6273(92)90115-T 10.1002/(SICI)1098-2299(199607/08)38:3/4290::AID-DDR183.0.CO;2-2 10.1016/0166-2236(90)90110-V 10.1212/WNL.45.6.1041 10.1016/0166-2236(89)90074-X 10.1093/brain/awl332 10.1152/jn.00768.2006 10.1523/JNEUROSCI.17-21-08498.1997 10.1073/pnas.81.8.2572 10.1002/1098-2396(20000915)37:4252::AID-SYN23.0.CO;2-A 10.1523/JNEUROSCI.11-08-02332.1991 10.1038/nmeth.2481 10.1523/JNEUROSCI.23-15-06245.2003 10.1073/pnas.87.18.7025 10.1016/S0028-3908(98)00131-2 10.1016/j.bcp.2007.06.015 10.1038/sj.mp.4002139 10.1016/j.bcp.2007.07.032 10.1016/j.tins.2004.06.010 10.1016/0306-4522(96)00011-5 10.1016/S0140-6736(77)91542-2 10.1523/JNEUROSCI.17-17-06761.1997 10.1016/j.neulet.2003.10.043 10.1016/0306-4522(83)90102-1 10.1254/jjp.86.429 10.0270-6474/00/202369-14 10.1097/00002826-199310000-00004 10.1016/j.clineuro.2012.03.046 10.1523/JNEUROSCI.0589-14.2014 10.1002/cne.903090308 10.1016/S0304-3940(00)01144-7 10.1016/j.neuint.2010.03.010 10.1038/nn.2984 10.1523/JNEUROSCI.11-10-03218.1991 10.1523/JNEUROSCI.22-14-06176.2002 10.1007/BF00231732 10.1016/S1474-4422(09)70287-X 10.1126/science.285.5434.1725 10.1523/JNEUROSCI.14-06-03969.1994 10.1016/j.neuron.2010.06.017 10.1002/mds.870050112 10.1523/JNEUROSCI.19-11-04682.1999 10.1523/JNEUROSCI.3833-10.2011 10.1016/S0140-6736(05)60822-7 10.1016/0022-510X(89)90042-7 10.1016/0306-4522(93)90489-3 10.1002/mds.23829 10.1016/S0306-4522(02)00267-1 10.1152/jn.00269.2013 10.1016/S0304-3940(02)00138-6 10.1021/cn500003z 10.1111/j.1476-5381.2010.01034.x 10.1124/mol.58.2.312 10.1371/journal.pone.0033348 10.1002/mds.870040301 10.1111/j.1460-9568.1998.00348.x 10.1111/j.1476-5381.1994.tb16171.x 10.1146/annurev.ph.57.030195.002513 10.1007/s11689-009-9033-8 10.1016/j.brainres.2007.04.034 10.1212/WNL.29.9_Part_1.1253 10.1016/j.neuron.2014.01.023 10.1007/s002210050876 10.1016/j.parkreldis.2013.02.007 |
| ContentType | Journal Article |
| Copyright | Copyright © 2014 Lim, Kang and McGehee. 2014 |
| Copyright_xml | – notice: Copyright © 2014 Lim, Kang and McGehee. 2014 |
| DBID | AAYXX CITATION NPM 7X8 5PM DOA |
| DOI | 10.3389/fnsyn.2014.00022 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Open Access Full Text |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1663-3563 |
| ExternalDocumentID | oai_doaj_org_article_1e675807e9c2422985ba3c6f53a21027 PMC4204445 25374536 10_3389_fnsyn_2014_00022 |
| Genre | Journal Article Review |
| GrantInformation_xml | – fundername: NCATS NIH HHS grantid: UL1 TR000430 |
| GroupedDBID | --- 53G 5VS 9T4 AAFWJ AAYXX ACGFO ACGFS ADBBV ADRAZ AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EMOBN GROUPED_DOAJ GX1 HYE KQ8 M48 M~E O5R O5S OK1 P6G PGMZT RNS RPM TR2 ACXDI IAO IEA IHR IPNFZ NPM RIG 7X8 5PM |
| ID | FETCH-LOGICAL-c4432-b8fa126dea8eb486c1ca0bac5558dc1dfa9f9ebf719be9905479ef60aeab7fdb3 |
| IEDL.DBID | M48 |
| ISSN | 1663-3563 |
| IngestDate | Wed Aug 27 01:17:07 EDT 2025 Thu Aug 21 18:17:26 EDT 2025 Fri Sep 05 07:29:56 EDT 2025 Thu Jan 02 22:15:19 EST 2025 Wed Sep 10 05:44:14 EDT 2025 Thu Apr 24 22:59:52 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | plasticity Parkinson's disease acetylcholine striatum cholinergic interneuron |
| Language | English |
| License | This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4432-b8fa126dea8eb486c1ca0bac5558dc1dfa9f9ebf719be9905479ef60aeab7fdb3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 Reviewed by: Maryka Quik, SRI International, USA; Teresa Morera-Herreras, University of the Basque Country, Spain Edited by: Sukumar Vijayaraghavan, University of Colorado Health Science Center, USA This article was submitted to the journal Frontiers in Synaptic Neuroscience. |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fnsyn.2014.00022 |
| PMID | 25374536 |
| PQID | 1622058328 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_1e675807e9c2422985ba3c6f53a21027 pubmedcentral_primary_oai_pubmedcentral_nih_gov_4204445 proquest_miscellaneous_1622058328 pubmed_primary_25374536 crossref_citationtrail_10_3389_fnsyn_2014_00022 crossref_primary_10_3389_fnsyn_2014_00022 |
| PublicationCentury | 2000 |
| PublicationDate | 20141021 |
| PublicationDateYYYYMMDD | 2014-10-21 |
| PublicationDate_xml | – month: 10 year: 2014 text: 20141021 day: 21 |
| PublicationDecade | 2010 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland |
| PublicationTitle | Frontiers in synaptic neuroscience |
| PublicationTitleAlternate | Front Synaptic Neurosci |
| PublicationYear | 2014 |
| Publisher | Frontiers Media S.A |
| Publisher_xml | – name: Frontiers Media S.A |
| References | De Rover (B92) 2002; 16 Ellens (B103) 2013; 3 Santangelo (B292) 2013b; 27 Linazasoro (B207) 1994; 9 Blandina (B38) 2012; 6 Mulder (B235) 1991; 102 Haydar (B146) 2010; 10 Hu (B161) 2002; 21 Perreault (B254) 2012; 7 Pourcher (B265) 1989; 4 Rinne (B284) 1991; 556 Whyte (B344) 1971; 4 Raedler (B276) 2003; 160 Gray (B133) 1996; 383 Gerfen (B120) 1987; 7 Nishiyama (B241) 2000; 408 Norgren (B242) 2006; 89 Todd (B330) 2003; 8 Li (B205) 2002; 324 Patrick (B249) 1993; 98 Alcantara (B4) 2001; 434 Smith (B307) 2000; 23 Wess (B342) 1996; 10 Chuhma (B68) 2011; 31 Berendse (B27) 1990; 299 Jucaite (B173) 2014; 231 Plotkin (B261) 2013; 110 West (B343) 2014; 522 Britt (B46) 2008; 28 Wallis (B338) 2009; 1 Moss (B234) 2008; 28 Sirvià (B304) 1989; 90 Gomez-Mancilla (B124) 1993; 16 Girod (B122) 2000; 39 Higley (B154) 2011; 6 Tashiro (B321) 1989; 97 Haj-Dahmane (B139) 1991; 41 Lanska (B194) 2010; 95 Nicholas (B240) 1992; 48 Zhou (B362) 2001; 4 Mori (B233) 2008; 115 McGeer (B228) 1977; 34 Zugno (B364) 2013; 28 Albin (B3) 1989; 12 Bolam (B41) 1986; 397 DeBoer (B86) 1993; 608 Kubota (B186) 1987; 413 Wilson (B346) 1990; 10 Bell (B25) 2000; 131 Perez (B251) 2012; 342 Dimova (B94) 1993; 53 Linden (B208) 1991; 7 Vuillet (B337) 1992; 46 Arenas (B15) 1991; 11 Diraddo (B99) 2014; 349 Landwehrmeyer (B192) 1995; 15 Dodt (B100) 1986; 380 Brown (B48) 1990; 55 Bonsi (B43) 2007; 32 Kelley (B179) 2004; 27 Martin-Schild (B222) 1999; 405 Manyam (B217) 1999; 80 Lehmann (B199) 1983; 10 Chung (B70) 2013; 10 Bernard (B31) 1992; 12 Ding (B98) 2011b; 108 Gotti (B126) 2006a; 23 Baba (B19) 2012; 114 Fino (B114) 2008; 586 Wilson (B347) 1981; 220 Aosaki (B8) 1996; 16 Dean (B85) 1996; 1 Picconi (B256) 2006; 22 Barroso-Chinea (B21) 2010; 4 Panula (B246) 1984; 81 Cepeda (B61) 2007; 81 Cantello (B56) 1986; 7 Hsu (B160) 1996; 73 Jin (B169) 1997; 355 Lesser (B203) 1979; 29 Bell (B26) 2002; 81 Jabourian (B167) 2005; 21 Crain (B76) 1996; 21 Gras (B132) 2008; 11 Calabresi (B51) 1998a; 10 Pancani (B245) 2014; 5 Kulak (B187) 2002; 303 MacDermott (B211) 1999; 22 Maurin (B226) 1999; 91 Timmerman (B329) 1989; 11 Sugita (B314) 1991; 88 Suzuki (B318) 2001b; 21 Yasuda (B356) 1993; 43 Huot (B162) 2007; 130 Calabresi (B53) 1998b; 43 Goetz (B123) 2011; 1 Fallon (B110) 1986; 249 Vilarà (B333) 1990; 114 Zhang (B361) 2006; 63 Cachope (B49) 2012; 2 Bernard (B30) 1998; 18 Hannestad (B141) 2013; 74 English (B105) 2011; 15 Bergson (B29) 1995; 15 Won (B348) 2014; 34 Pérez-Garci (B250) 2003; 14 Quik (B271) 2006; 316 English (B104) 2009; 1 Haas (B137) 2008; 88 Hyland (B163) 2002; 114 Raudino (B278) 2012; 33 Arenas (B16) 1990; 523 Feng (B111) 2014; 255 Suzuki (B317) 2001a; 41 Mulder (B236) 1984; 308 Scheibler (B294) 2004; 143 RodrÃguez (B286) 1999; 19 Koob (B182) 1992; 654 Prast (B266) 1999a; 360 Dawson (B84) 1990; 25 Dale (B80) 1910; 41 Da Cunha (B78) 2012; 23 Piggott (B257) 2003; 25 RodrÃguez-Pallares (B287) 2000; 876 Sandor (B290) 1991; 567 Gasser (B119) 2009; 11 Cossette (B74) 2005; 29 Parsons (B248) 2006; 147 Aosaki (B10) 1994; 14 Zhou (B363) 2006; 96 Testa (B323) 1994; 14 Smolders (B308) 1997; 68 Claye (B71) 1996; 277 Calabresi (B50) 1997; 17 Quik (B270) 2007; 74 Dubach (B101) 1987; 75 Marchi (B218) 2002; 80 Szydlowski (B319) 2013; 33 Thomas (B324) 2000; 37 Dani (B81) 2001; 49 Centonze (B59) 2001; 21 Deng (B90) 2007a; 27 Weiner (B341) 1990; 87 Matsuda (B225) 2009; 29 Nelson (B239) 2014b; 82 Chudasama (B66) 2006; 73 Le Novère (B201) 1996; 8 Bernard (B32) 1997; 17 DeLong (B89) 1990; 13 Macintosh (B212) 1941; 99 Martella (B221) 2009; 215 Abercrombie (B1) 1997; 17 Enna (B106) 1976a; 116 Hauser (B145) 1993; 8 Inokawa (B166) 2010; 168 Enna (B107) 1976b; 294 Jackisch (B168) 1993; 348 Contant (B73) 1996; 71 Hattori (B143) 1991; 309 Calabresi (B52) 1999; 158 Koranda (B183) 2014; 111 Aouizerate (B11) 2004; 72 Court (B75) 2000; 98 Hayslett (B147) 2003; 76 Zhang (B358) 2013; 347 Threlfell (B325) 2010; 30 Lange (B193) 1993; 60 Martone (B223) 1992; 594 Matsubayashi (B224) 2001; 86 Vorobjev (B336) 2000; 12 Hristova (B159) 2000; 17 Liu (B209) 2007; 98 Fisher (B115) 2000; 39 Sharples (B297) 2000; 20 Leonard (B202) 2002; 59 Bain (B20) 2013; 38 Mansour (B215) 1994; 350 Standaert (B310) 1999; 64 Ahlskog (B2) 2001; 16 Beaulieu (B23) 2011; 63 Kawaguchi (B177) 1993; 13 Allam (B5) 2004; 15 Klink (B181) 2001; 21 Straub (B312) 2014; 34 Luo (B210) 2013; 591 Guan (B135) 2009; 14 Tso (B332) 2003; 30 Gotti (B127) 2006b; 27 Lee (B197) 1998; 510(Pt 2) Gilman (B121) 2010; 74 Hebb (B148) 1961; 189 Preston (B268) 2000; 95 Bonsi (B44) 2004; 11 Del Barrio (B88) 2011; 162 Durany (B102) 2000; 287 Chen (B65) 1996; 73 Jollivet (B171) 2004; 362 Apicella (B12) 1997; 116 Innis (B165) 1987; 143 Stuber (B313) 2010; 30 Hong (B157) 2004; 355 Carpenedo (B57) 2001; 13 Arbuthnott (B14) 2007; 30 Hattori (B142) 1976; 102 Sprouse (B309) 1989; 167 Grace (B130) 1984; 4 Ragozzino (B277) 2003; 80 Pisani (B260) 2003; 23 Shytle (B301) 1996; 38 Yan (B354) 2001; 103 Birket-Smith (B37) 1974; 50 Chang (B64) 2001; 32 Malenka (B214) 1988; 8 Berg (B28) 2007; 27 Kravitz (B185) 2010; 466 Chung (B69) 2010; 75 Brown (B47) 2012; 492 Pisani (B258) 2002; 22 Dautan (B82) 2014; 34 Lehmann (B198) 1982; 248 Fernandez (B113) 2012; 79 Simón-Sánchez (B303) 2009; 41 Wu (B352) 2009; 108 Sanberg (B289) 1998; 352 Aubert (B17) 1992; 58 Woolf (B351) 1984; 13 Hersch (B152) 1994; 14 Parkinson (B247) 1817 Tallaksen-Greene (B320) 1998; 780 Watanabe (B340) 1998; 79 Marchi (B219) 1990; 116 Mulle (B237) 1992; 8 Gonzales (B125) 2013; 521 Mirenowicz (B231) 1996; 379 Ovallath (B243) 2013; 28 Surmeier (B316) 2007; 30 Cepeda (B60) 2001; 14 Ding (B97) 2011a; 106 Bolam (B42) 1984; 12 Quik (B274) 2011; 63 Santangelo (B291) 2013a; 19 Wilens (B345) 2007; 74 Chuhma (B67) 2014; 81 Wan (B339) 1999; 285 Higashi (B153) 2007; 1155 Altier (B6) 2012; 63 Azam (B18) 2003; 119 Hauber (B144) 1994; 60 Richardson (B283) 2000; 74 Chang (B62) 1988; 21 Gross (B134) 1990; 87 Cubo (B77) 2008; 30 Levey (B204) 1991; 11 Apicella (B13) 1991; 85 Grady (B131) 2007; 74 Kaiser (B174) 2000; 58 Poewe (B262) 2006; 21 Yan (B355) 1997; 77 Silver (B302) 2000; 10 Holt (B156) 1999; 94 Aosaki (B9) 1998; 18 Shen (B298) 2005; 25 Johnson (B170) 1995; 67 Robinson (B285) 2000; 95 Ravel (B279) 1999; 128 Smith (B306) 2006; 15 Tepper (B322) 2010; 4 Galarraga (B117) 1999; 19 Fenster (B112) 1997; 17 Jones (B172) 2001; 439 Lee (B196) 2008; 7 Voorn (B335) 2004; 27 Bordia (B45) 2010; 333 Yin (B357) 2010; 30 Keath (B178) 2007; 98 Potter (B264) 2014; 75 Quik (B272) 2012; 27 Radek (B275) 2010; 16 Ding (B96) 2006; 9 Exley (B108) 2013; 22 Kimura (B180) 1984; 81 Markram (B220) 1997; 275 Prast (B267) 1999b; 360 Manyam (B216) 1990; 5 Persohn (B255) 1992; 326 Bar-Shira (B22) 2014; 35 Katzenschlager (B176) 2003 Hellström-Lindahl (B149) 2000; 113 Le Moine (B200) 1994; 62 Ponterio (B263) 2013; 75 Kostic (B184) 1991; 41 Perez-Rosello (B253) 2005; 93 Wonnacott (B349) 2000; 393 Pakhotin (B244) 2007; 27 Beggiato (B24) 2013; 37 Shimohama (B300) 1985; 45 Woolf (B350) 1981; 7 McGehee (B230) 1995; 57 Devan (B93) 2011; 96 Götz (B128) 1997; 17 Künzle (B190) 1975; 88 Reynolds (B280) 2004; 24 Howe (B158) 1995; 15 Morens (B232) 1995; 45 Nelson (B238) 2014a; 34 Pisani (B259) 2001; 40 Bird (B35) 1974; 97 Lapper (B195) 1992; 51 Kumar (B189) 2009; 615 Quik (B273) 2003; 63 Sullivan (B315) 2008; 28 Kumar (B188) 2005; 20 Kurokawa (B191) 1994; 113 Shiflett (B299) 2010; 30 Zhang (B360) 2002; 22 Voon (B334) 2009; 8 Rezvani (B281) 2012; 223 Smiley (B305) 1999; 90 Stephenson-Jones (B311) 2011; 21 Bettler (B34) 2004; 84 Conn (B72) 2005; 6 Hernández-Echeagaray (B151) 1998; 37 McEvoy (B227) 2002; 1 Xiao (B353) 2009; 29 Betarbet (B33) 1997; 17 Campos (B55) 2010; 56 Schwartz (B296) 1986; 124 Centonze (B58) 2003; 23 Rojas (B288) 2013; 83 Bird (B36) 1977; 2 Bohr (B40) 2005; 191 Tritsch (B331) 2012; 490 Henny (B150) 2012; 15 Rice (B282) 2004; 7 Schoffelmeer (B295) 1997; 122 AncÃn (B7) 2010; 20 Hiley (B155) 1974; 80 Guatteo (B136) 2013; 247 Threlfell (B327) 2012; 75 Blomeley (B39) 2005; 569 Kataoka (B175) 2010; 518 Calabresi (B54) 1996; 47 McGehee (B229) 1995; 269 Fox (B116) 2011; 26 Lin (B206) 2004; 20 DeBoer (B87) 1994; 62 Haber (B138) 2000; 20 Dalack (B79) 1998; 155 Garcia-Munoz (B118) 1996; 277 Hammond (B140) 1988; 50 Dawson (B83) 1988; 42 Fabbrini (B109) 2007; 22 Perez (B252) 2013; 127 Mahon (B213) 2004; 27 Zhang (B359) 2004; 7 Ding (B95) 2010; 67 Sato (B293) 2014; 263 Puttfarcken (B269) 2000; 39 Threlfell (B326) 2011; 5 Deng (B91) 2007b; 33 Tian (B328) 2011; 1381 Chang (B63) 1992; 574 Ibáñez-Sandoval (B164) 2010; 30 8947924 - Neurochem Res. 1996 Nov;21(11):1347-51 19445928 - Eur J Pharmacol. 2009 Aug 1;615(1-3):91-101 17631864 - Biochem Pharmacol. 2007 Oct 15;74(8):1224-34 2432992 - Brain Res. 1986 Nov 12;397(2):279-89 17446041 - J Chem Neuroanat. 2007 Jul;33(4):167-92 18343255 - Clin Ther. 2008 Jan;30(1):182-9 20484642 - J Neurosci. 2010 May 19;30(20):6999-7016 20463630 - Psychiatr Genet. 2010 Dec;20(6):289-97 2479133 - Trends Neurosci. 1989 Oct;12(10):366-75 1672454 - Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2608-11 8003250 - Behav Brain Res. 1994 Feb 28;60(2):211-5 11983282 - Neurosci Lett. 2002 May 10;324(1):9-12 1488113 - Neuroscience. 1992 Dec;51(3):533-45 3514543 - Ital J Neurol Sci. 1986 Feb;7(1):139-43 15345659 - Br J Pharmacol. 2004 Sep;143(1):119-31 7685068 - Neuroscience. 1993 Apr;53(4):1059-71 9812108 - Am J Psychiatry. 1998 Nov;155(11):1490-501 23345240 - J Neurosci. 2013 Jan 23;33(4):1678-83 16699510 - Nat Neurosci. 2006 Jun;9(6):832-42 16026468 - Eur J Neurosci. 2005 Jun;21(12):3301-9 16987871 - Hum Mol Genet. 2006 Nov 1;15(21):3119-31 22327472 - Nat Neurosci. 2012 Feb 12;15(4):613-9 17825262 - Biochem Pharmacol. 2007 Oct 15;74(8):1235-46 50112 - Brain Res. 1975 May 2;88(2):195-209 11043817 - Drugs Aging. 2000 Sep;17(3):165-81 10973600 - Brain Res. 2000 Sep 8;876(1-2):124-30 15615835 - J Neurophysiol. 2005 May;93(5):2507-19 23032073 - Neuropsychopharmacology. 2013 Feb;38(3):405-13 10933116 - J Child Adolesc Psychopharmacol. 2000 Summer;10(2):59-68 9109520 - J Neurochem. 1997 May;68(5):1942-8 2964509 - J Neurochem. 1988 Apr;50(4):1111-6 18272687 - J Neurosci. 2008 Feb 13;28(7):1672-81 21700460 - Curr Biol. 2011 Jul 12;21(13):1081-91 10891862 - Synapse. 2000 Sep 15;37(4):252-61 19631006 - Expert Rev Mol Med. 2009 Jul 27;11:e22 16759874 - Neurobiol Dis. 2006 Aug;23(2):481-9 16402096 - Br J Pharmacol. 2006 Jan;147 Suppl 1:S127-35 9582229 - J Neurophysiol. 1998 May;79(5):2568-80 7845412 - Mov Disord. 1994 Nov;9(6):689 17427940 - Mov Disord. 2007 Jul 30;22(10):1379-89; quiz 1523 24528004 - ACS Chem Neurosci. 2014 Apr 16;5(4):318-24 14729237 - Neurosci Lett. 2004 Jan 23;355(1-2):69-72 24613418 - Neuron. 2014 Apr 2;82(1):63-70 10854724 - Neurosci Lett. 2000 Jun 23;287(2):109-12 2723671 - J Neurol Sci. 1989 Mar;90(1):23-32 11301208 - Neuroscience. 2001;103(4):1017-24 11517238 - J Neurosci. 2001 Sep 1;21(17):6492-501 23490464 - Parkinsonism Relat Disord. 2013 Jul;19(7):645-53 15580606 - Mov Disord. 2005 Mar;20(3):342-4 14643839 - Pharmacol Biochem Behav. 2003 Dec;76(3-4):409-15 11713470 - Nat Neurosci. 2001 Dec;4(12):1224-9 11160411 - J Neurosci. 2001 Feb 15;21(4):1393-400 1729398 - J Neurochem. 1992 Feb;58(2):529-41 11391738 - Mov Disord. 2001 May;16(3):448-58 10646537 - J Neurochem. 2000 Feb;74(2):839-46 11596051 - J Comp Neurol. 2001 Oct 15;439(2):235-47 1834312 - Brain Res. 1991 Aug 9;556(1):117-22 12122076 - J Neurosci. 2002 Jul 15;22(14):6176-85 8757038 - Neurology. 1996 Aug;47(2):557-62 12695545 - Mol Pharmacol. 2003 May;63(5):1169-79 9065864 - J Neurophysiol. 1997 Feb;77(2):1003-15 11222635 - J Neurosci. 2001 Mar 1;21(5):1452-63 9254687 - J Neurosci. 1997 Sep 1;17(17):6761-8 8106150 - Clin Neuropharmacol. 1993 Oct;16(5):418-27 15019426 - Neurosci Biobehav Rev. 2004 Jan;27(8):765-76 16995263 - J Physiol. 1941 Jun 30;99(4):436-42 8182455 - J Neurosci. 1994 May;14(5 Pt 2):3005-18 17408758 - Trends Neurosci. 2007 May;30(5):228-35 18180757 - Mol Psychiatry. 2009 May;14(5):546-54 23079510 - Rev Neurosci. 2012;23(5-6):747-67 18753369 - J Neurosci. 2008 Aug 27;28(35):8682-90 9585352 - Ann Neurol. 1998 May;43(5):586-97 12505810 - Am J Psychiatry. 2003 Jan;160(1):118-27 21241679 - Brain Res. 2011 Mar 24;1381:228-36 8667239 - J Pharmacol Exp Ther. 1996 Jun;277(3):1685-93 6150070 - J Neurosci. 1984 Nov;4(11):2866-76 24632480 - Exp Neurol. 2014 May;255:154-60 17215400 - J Neurosci. 2007 Jan 10;27(2):391-400 2874159 - J Comp Neurol. 1986 Jul 15;249(3):293-336 9045723 - J Neurosci. 1997 Mar 15;17(6):1940-9 19144844 - J Neurosci. 2009 Jan 14;29(2):444-53 15649484 - Exp Neurol. 2005 Feb;191(2):292-300 8613942 - J Pharmacol Exp Ther. 1996 Apr;277(1):359-65 22219231 - Cleve Clin J Med. 2012 Jan;79(1):28-35 4733 - N Engl J Med. 1976 Jun 10;294(24):1305-9 15269338 - Physiol Rev. 2004 Jul;84(3):835-67 23891638 - Neuropharmacology. 2013 Dec;75:78-85 17699666 - J Neurosci. 2007 Aug 15;27(33):8845-56 9705995 - J Physiol. 1998 Jul 15;510 ( Pt 2):441-53 10410773 - Adv Neurol. 1999;80:565-74 4278580 - Brain Res. 1974 Nov 15;80(2):355-8 23034651 - Nature. 2012 Oct 11;490(7419):262-6 22526540 - Psychopharmacology (Berl). 2012 Oct;223(3):251-8 16993030 - J Physiol. 1910 Dec 31;41(5):318-44 19812319 - J Neurosci. 2009 Oct 7;29(40):12428-39 15271494 - Trends Neurosci. 2004 Aug;27(8):468-74 2395528 - Neurosci Lett. 1990 Jul 3;114(2):154-9 22005945 - Neurol Sci. 2012 Aug;33(4):945-8 21187382 - Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):840-5 6322011 - Nature. 1984 Mar 15-21;308(5956):278-80 1695404 - Trends Neurosci. 1990 Jul;13(7):281-5 10218781 - Neuroscience. 1999 Mar;90(3):803-14 2355224 - J Neurochem. 1990 Jul;55(1):31-8 15537735 - Learn Mem. 2004 Nov-Dec;11(6):755-60 2402490 - Proc Natl Acad Sci U S A. 1990 Sep;87(18):7050-4 2149667 - Brain Res Bull. 1990 Dec;25(6):903-12 8878480 - Nature. 1996 Oct 24;383(6602):713-6 23161142 - Subcell Biochem. 2012;63:241-62 18278042 - Nat Neurosci. 2008 Mar;11(3):292-300 12867509 - J Neurosci. 2003 Jul 16;23(15):6245-54 19909912 - Lancet Neurol. 2009 Dec;8(12):1140-9 2172326 - J Comp Neurol. 1990 Sep 8;299(2):187-228 23841846 - Eur J Neurosci. 2013 Oct;38(7):3036-43 22794260 - Neuron. 2012 Jul 12;75(1):58-64 19941350 - J Comp Neurol. 2010 Feb 1;518(3):277-91 21544206 - PLoS One. 2011 Apr 22;6(4):e19155 12706204 - J Chem Neuroanat. 2003 Mar;25(3):161-73 11422455 - Eur J Neurosci. 2001 Jun;13(11):2141-7 8232601 - Naunyn Schmiedebergs Arch Pharmacol. 1993 Sep;348(3):234-41 8613722 - J Neurosci. 1995 Dec;15(12):7821-36 2572435 - Eur J Pharmacol. 1989 Aug 29;167(3):375-83 10098939 - J Comp Neurol. 1999 Mar 22;405(4):450-71 23773793 - Biol Psychiatry. 2013 Nov 15;74(10):768-76 17974593 - J Physiol. 2008 Jan 1;586(1):265-82 1717519 - J Comp Neurol. 1991 Jul 15;309(3):391-401 23856296 - Biol Psychiatry. 2014 Feb 1;75(3):207-14 22516415 - Clin Neurol Neurosurg. 2012 Dec;114(10):1308-11 12492422 - Eur J Neurosci. 2002 Dec;16(12):2279-90 20181592 - J Neurosci. 2010 Feb 24;30(8):2951-9 10658616 - Neuroscience. 2000;95(2):367-76 23902940 - J Pharmacol Exp Ther. 2013 Oct;347(1):225-34 11953457 - J Neurochem. 2002 Mar;80(6):1071-8 21547719 - J Neurodev Disord. 2009 Dec;1(4):252-63 8809795 - Neuroscience. 1996 Aug;73(3):751-60 1280527 - Brain Res. 1992 Oct 30;594(2):253-62 2687795 - Pharm Weekbl Sci. 1989 Oct 20;11(5):146-50 6371818 - Proc Natl Acad Sci U S A. 1984 Apr;81(8):2572-6 15525771 - J Neurosci. 2004 Nov 3;24(44):9870-7 9822774 - J Neurosci. 1998 Dec 1;18(23):10207-18 11738031 - Neuron. 2001 Dec 6;32(5):855-65 23296794 - J Comp Neurol. 2013 Aug 1;521(11):2502-22 7317794 - Brain Res Bull. 1981 Nov;7(5):487-507 17512502 - Brain Res. 2007 Jun 25;1155:208-19 8207500 - J Neurosci. 1994 Jun;14(6):3969-84 4155220 - Acta Neurol Scand. 1974;50(6):801-11 10770997 - Eur J Pharmacol. 2000 Mar 30;393(1-3):51-8 22693036 - Mov Disord. 2012 Jul;27(8):947-57 8248498 - Prog Brain Res. 1993;98:113-20 12832552 - J Neurosci. 2003 Jun 15;23(12):5272-82 24671996 - J Neurosci. 2014 Mar 26;34(13):4509-18 1941081 - J Neurosci. 1991 Oct;11(10):3218-26 7675190 - Neuroscience. 1995 Aug;67(3):609-23 8684624 - Neuroscience. 1996 Apr;71(4):937-47 8809793 - Neuroscience. 1996 Aug;73(3):715-31 2883616 - Neurosci Lett. 1987 Mar 31;75(2):205-10 12151512 - J Neurosci. 2002 Aug 1;22(15):6347-52 8182478 - J Neurosci. 1994 May;14(5 Pt 2):3351-63 2404203 - Mov Disord. 1990;5(1):47-8 2848109 - J Neurosci. 1988 Oct;8(10):3750-6 1542411 - Neuroscience. 1992;46(2):351-60 15146188 - Nat Neurosci. 2004 Jun;7(6):583-4 10908298 - Mol Pharmacol. 2000 Aug;58(2):312-8 10202545 - Annu Rev Neurosci. 1999;22:443-85 20439843 - Neurology. 2010 May 4;74(18):1416-23 21273403 - J Neurosci. 2011 Jan 26;31(4):1183-92 12556914 - Mol Psychiatry. 2003 Jan;8(1):103-8 8987749 - J Neurosci. 1997 Jan 1;17(1):204-15 6589643 - Proc Natl Acad Sci U S A. 1984 Aug;81(15):4998-5001 23481547 - Exp Neurol. 2013 Sep;247:582-94 11230867 - Biol Psychiatry. 2001 Feb 1;49(3):166-74 24089398 - J Neurophysiol. 2014 Jan;111(1):103-11 17689498 - Biochem Pharmacol. 2007 Oct 15;74(8):1212-23 23045343 - J Physiol. 2013 Jan 1;591(1):203-17 9886672 - Neuropharmacology. 1998 Dec;37(12 ):1493-502 1638402 - Brain Res. 1992 Mar 6;574(1-2):307-11 1817734 - Brain Res. 1991 Dec 20;567(2):313-6 1992362 - Neurology. 1991 Feb;41(2 ( Pt 1)):202-5 7778876 - Annu Rev Physiol. 1995;57:521-46 15130710 - Prog Neurobiol. 2004 Feb;72(3):195-221 1976420 - Brain Res. 1990 Jul 16;523(1):51-6 6168334 - Brain Res. 1981 Sep 7;220(1):67-80 8950106 - Eur J Neurosci. 1996 Nov;8(11):2428-39 23483637 - Mov Disord. 2013 May;28(5):566-8 19915575 - Nat Genet. 2009 Dec;41(12):1308-12 4948768 - Eur J Clin Pharmacol. 1971 Dec;4(1):18-21 15271493 - Trends Neurosci. 2004 Aug;27(8):460-7 17942622 - J Neurophysiol. 2007 Dec;98(6):3388-96 24948810 - J Neurosci. 2014 Jun 18;34(25):8557-69 11343292 - J Comp Neurol. 2001 Jun 11;434(4):445-60 7870294 - Neuroscience. 1994 Oct;62(3):635-40 4157009 - Brain. 1974 Sep;97(3):457-72 12388645 - J Pharmacol Exp Ther. 2002 Nov;303(2):633-9 8756443 - J Neurosci. 1996 Aug 15;16(16):5141-53 73064 - Lancet. 1977 Dec 3;2(8049):1157-8 20203199 - J Neurosci. 2010 Mar 3;30(9):3398-408 24559678 - Neuron. 2014 Feb 19;81(4):901-12 10971630 - Eur J Neurosci. 2000 Aug;12(8):2871-80 21427783 - Front Syst Neurosci. 2011 Mar 03;5:11 22229124 - Cold Spring Harb Perspect Med. 2011 Sep;1(1):a008862 8559249 - Nature. 1996 Feb 1;379(6564):449-51 23348498 - Mol Pharmacol. 2013 Apr;83(4):746-52 1309647 - Neuron. 1992 Jan;8(1):135-43 23178810 - Nature. 2012 Dec 20;492(7429):452-6 10341266 - J Neurosci. 1999 Jun 1;19(11):4682-94 22428025 - PLoS One. 2012;7(3):e33348 12067226 - J Neurochem. 2002 Apr;81(1):142-9 22586376 - Front Syst Neurosci. 2012 May 04;6:33 11044737 - Neuropharmacology. 2000 Oct;39(13):2673-80 8985014 - S |
| References_xml | – volume: 20 start-page: 1219 year: 2004 ident: B206 article-title: Effects of muscarinic acetylcholine receptor activation on membrane currents and intracellular messengers in medium spiny neurones of the rat striatum publication-title: Eur. J. Neurosci doi: 10.1111/j.1460-9568.2004.03576.x – volume: 80 start-page: 565 year: 1999 ident: B217 article-title: Traditional and complementary therapies in Parkinson's disease publication-title: Adv. Neurol – volume: 37 start-page: 1470 year: 2013 ident: B24 article-title: Kynurenic acid, by targeting α7 nicotinic acetylcholine receptors, modulates extracellular GABA levels in the rat striatum in vivo publication-title: Eur. J. Neurosci doi: 10.1111/ejn.12160 – volume: 7 start-page: 81 year: 1991 ident: B208 article-title: A long-term depression of AMPA currents in cultured cerebellar Purkinje neurons publication-title: Neuron doi: 10.1016/0896-6273(91)90076-C – volume: 155 start-page: 1490 year: 1998 ident: B79 article-title: Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings publication-title: Am. J. Psychiatry doi: 10.1176/ajp.155.11.1490 – volume: 215 start-page: 388 year: 2009 ident: B221 article-title: Enhanced sensitivity to group II mGlu receptor activation at corticostriatal synapses in mice lacking the familial parkinsonism-linked genes PINK1 or Parkin publication-title: Exp. Neurol doi: 10.1016/j.expneurol.2008.11.001 – volume: 10 start-page: 59 year: 2000 ident: B302 article-title: Mecamylamine in Tourette's syndrome: a two-year retrospective case study publication-title: J. Child Adolesc. Psychopharmacol doi: 10.1089/cap.2000.10.59 – volume: 74 start-page: 768 year: 2013 ident: B141 article-title: Changes in the cholinergic system between bipolar depression and euthymia as measured with [123I]5IA single photon emission computed tomography publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2013.04.004 – volume: 89 start-page: 531 year: 2006 ident: B242 article-title: Gustatory reward and the nucleus accumbens publication-title: Physiol. Behav doi: 10.1016/j.physbeh.2006.05.024 – volume: 466 start-page: 622 year: 2010 ident: B185 article-title: Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry publication-title: Nature doi: 10.1038/nature09159 – volume: 34 start-page: 3090 year: 2014 ident: B348 article-title: Striatal cholinergic cell ablation attenuates L-DOPA induced dyskinesia in Parkinsonian mice publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.2888-13.2014 – volume: 18 start-page: 5180 year: 1998 ident: B9 article-title: Dopamine D1-like receptor activation excites rat striatal large aspiny neurons in vitro publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.18-14-05180.1998 – volume: 492 start-page: 452 year: 2012 ident: B47 article-title: Ventral tegmental area GABA projections pause accumbal cholinergic interneurons to enhance associative learning publication-title: Nature doi: 10.1038/nature11657 – volume: 11 start-page: 755 year: 2004 ident: B44 article-title: Coordinate high-frequency pattern of stimulation and calcium levels control the induction of LTP in striatal cholinergic interneurons publication-title: Learn. Mem doi: 10.1101/lm.82104 – volume: 21 start-page: 616 year: 2002 ident: B161 article-title: Nicotinic regulation of CREB activation in hippocampal neurons by glutamatergic and nonglutamatergic pathways publication-title: Mol. Cell. Neurosci doi: 10.1006/mcne.2002.1202 – volume: 14 start-page: 1253 year: 2003 ident: B250 article-title: The role of Ca2+ channels in the repetitive firing of striatal projection neurons publication-title: Neuroreport doi: 10.1097/01.wnr.0000081861.45938.71 – volume: 55 start-page: 31 year: 1990 ident: B48 article-title: Both A1 and A2a purine receptors regulate striatal acetylcholine release publication-title: J. Neurochem doi: 10.1111/j.1471-4159.1990.tb08817.x – volume: 29 start-page: 12428 year: 2009 ident: B353 article-title: Chronic nicotine selectively enhances alpha4beta2* nicotinic acetylcholine receptors in the nigrostriatal dopamine pathway publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.2939-09.2009 – volume: 28 start-page: 501 year: 2013 ident: B364 article-title: Rivastigmine reverses cognitive deficit and acetylcholinesterase activity induced by ketamine in an animal model of schizophrenia publication-title: Metab. Brain Dis doi: 10.1007/s11011-013-9417-z – volume: 73 start-page: 751 year: 1996 ident: B160 article-title: Carbachol induces inward current in neostriatal neurons through M1-like muscarinic receptors publication-title: Neuroscience doi: 10.1016/0306-4522(96)00066-8 – volume: 4 start-page: 1224 year: 2001 ident: B362 article-title: Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum publication-title: Nat. Neurosci doi: 10.1038/nn769 – volume: 21 start-page: 456 year: 2006 ident: B262 article-title: Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: an active treatment extension study publication-title: Mov. Disord. Off. J. Mov. Disord. Soc doi: 10.1002/mds.20700 – volume: 30 start-page: 3398 year: 2010 ident: B325 article-title: Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.5620-09.2010 – volume: 574 start-page: 307 year: 1992 ident: B63 article-title: Interneurons in the rat striatum: relationships between parvalbumin neurons and cholinergic neurons publication-title: Brain Res doi: 10.1016/0006-8993(92)90830-3 – volume: 27 start-page: 765 year: 2004 ident: B179 article-title: Ventral striatal control of appetitive motivation: role in ingestive behavior and reward-related learning publication-title: Neurosci. Biobehav. Rev doi: 10.1016/j.neubiorev.2003.11.015 – volume: 434 start-page: 445 year: 2001 ident: B4 article-title: Muscarinic m1 and m2 receptor proteins in local circuit and projection neurons of the primate striatum: anatomical evidence for cholinergic modulation of glutamatergic prefronto-striatal pathways publication-title: J. Comp. Neurol doi: 10.1002/cne.1186 – volume: 98 start-page: 79 year: 2000 ident: B75 article-title: Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication publication-title: Neuroscience doi: 10.1016/S0306-4522(00)00071-3 – volume: 167 start-page: 375 year: 1989 ident: B309 article-title: MDMA (3,4-methylenedioxymethamphetamine) inhibits the firing of dorsal raphe neurons in brain slices via release of serotonin publication-title: Eur. J. Pharmacol doi: 10.1016/0014-2999(89)90446-9 – volume: 6 issue: 33 year: 2012 ident: B38 article-title: Histamine neurons in the tuberomamillary nucleus: a whole center or distinct subpopulations? publication-title: Front. Syst. Neurosci doi: 10.3389/fnsys.2012.00033 – volume: 30 start-page: 6999 year: 2010 ident: B164 article-title: Electrophysiological and morphological characteristics and synaptic connectivity of tyrosine hydroxylase-expressing neurons in adult mouse striatum publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.5996-09.2010 – volume: 30 start-page: 182 year: 2008 ident: B77 article-title: Donepezil use in children and adolescents with tics and attention-deficit/hyperactivity disorder: an 18-week, single-center, dose-escalating, prospective, open-label study publication-title: Clin. Ther doi: 10.1016/j.clinthera.2008.01.010 – volume: 32 start-page: 855 year: 2001 ident: B64 article-title: Voltage-gated channels block nicotinic regulation of CREB phosphorylation and gene expression in neurons publication-title: Neuron doi: 10.1016/S0896-6273(01)00516-5 – volume: 102 start-page: 164 year: 1976 ident: B142 article-title: Immunohistochemical localization of choline acetyltransferase containing neostriatal neurons and their relationship with dopaminergic synapses publication-title: Brain Res doi: 10.1016/0006-8993(76)90583-7 – volume: 231 start-page: 1251 year: 2014 ident: B173 article-title: A randomized, double-blind, placebo-controlled crossover study of α4β 2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder publication-title: Psychopharmacology (Berl.) doi: 10.1007/s00213-013-3116-7 – volume: 4 start-page: 18 year: 1971 ident: B344 article-title: Levodopa and orphenadrine hydrochloride in Parkinsonism publication-title: Eur. J. Clin. Pharmacol doi: 10.1007/BF00568893 – volume: 63 start-page: 241 year: 2012 ident: B6 article-title: GPCR and voltage-gated calcium channels (VGCC) signaling complexes publication-title: Subcell. Biochem doi: 10.1007/978-94-007-4765-4_13 – volume: 13 start-page: 4908 year: 1993 ident: B177 article-title: Physiological, morphological, and histochemical characterization of three classes of interneurons in rat neostriatum publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.13-11-04908.1993 – volume: 11 start-page: 146 year: 1989 ident: B329 article-title: Histamine receptors in the central nervous system publication-title: Pharm. Weekbl. Sci doi: 10.1007/BF01959461 – volume: 7 start-page: 487 year: 1981 ident: B350 article-title: Cholinergic neurons in the caudate-putamen complex proper are intrinsically organized: a combined Evans blue and acetylcholinesterase analysis publication-title: Brain Res. Bull doi: 10.1016/0361-9230(81)90004-6 – volume: 27 start-page: 391 year: 2007 ident: B244 article-title: Cholinergic interneurons control the excitatory input to the striatum publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.3709-06.2007 – volume: 33 start-page: 945 year: 2012 ident: B278 article-title: The parkinson disease before james parkinson publication-title: Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol doi: 10.1007/s10072-011-0816-9 – volume: 10 start-page: 144 year: 2010 ident: B146 article-title: Neuronal nicotinic acetylcholine receptors - targets for the development of drugs to treat cognitive impairment associated with schizophrenia and Alzheimer's disease publication-title: Curr. Top. Med. Chem doi: 10.2174/156802610790410983 – volume: 379 start-page: 449 year: 1996 ident: B231 article-title: Preferential activation of midbrain dopamine neurons by appetitive rather than aversive stimuli publication-title: Nature doi: 10.1038/379449a0 – volume: 349 start-page: 373 year: 2014 ident: B99 article-title: A real-time method for measuring cAMP production modulated by Gαi/o-coupled metabotropic glutamate receptors publication-title: J. Pharmacol. Exp. Ther doi: 10.1124/jpet.113.211532 – volume: 249 start-page: 293 year: 1986 ident: B110 article-title: Distribution of dynorphin and enkephalin peptides in the rat brain publication-title: J. Comp. Neurol doi: 10.1002/cne.902490302 – volume: 11 start-page: e22 year: 2009 ident: B119 article-title: Molecular pathogenesis of Parkinson disease: insights from genetic studies publication-title: Expert Rev. Mol. Med doi: 10.1017/S1462399409001148 – volume: 113 start-page: 159 year: 2000 ident: B149 article-title: Nicotinic acetylcholine receptors during prenatal development and brain pathology in human aging publication-title: Behav. Brain Res doi: 10.1016/S0166-4328(00)00210-2 – volume: 21 start-page: 3301 year: 2005 ident: B167 article-title: Functional mu opioid receptors are expressed in cholinergic interneurons of the rat dorsal striatum: territorial specificity and diurnal variation publication-title: Eur. J. Neurosci doi: 10.1111/j.1460-9568.2005.04154.x – volume: 63 start-page: 1169 year: 2003 ident: B273 article-title: Differential declines in striatal nicotinic receptor subtype function after nigrostriatal damage in mice publication-title: Mol. Pharmacol doi: 10.1124/mol.63.5.1169 – volume: 147 start-page: S127 year: 2006 ident: B248 article-title: Histamine and its receptors publication-title: Br. J. Pharmacol doi: 10.1038/sj.bjp.0706440 – volume: 98 start-page: 113 year: 1993 ident: B249 article-title: Functional diversity of neuronal nicotinic acetylcholine receptors publication-title: Prog. Brain Res doi: 10.1016/S0079-6123(08)62387-0 – volume: 119 start-page: 965 year: 2003 ident: B18 article-title: Co-expression of alpha7 and beta2 nicotinic acetylcholine receptor subunit mRNAs within rat brain cholinergic neurons publication-title: Neuroscience doi: 10.1016/S0306-4522(03)00220-3 – volume: 277 start-page: 1685 year: 1996 ident: B118 article-title: Effects of nicotine on dopaminergic nigrostriatal axons requires stimulation of presynaptic glutamatergic receptors publication-title: J. Pharmacol. Exp. Ther doi: 10.1016/S0022-3565(25)13124-8 – volume: 16 start-page: 448 year: 2001 ident: B2 article-title: Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature publication-title: Mov. Disord. Off. J. Mov. Disord. Soc doi: 10.1002/mds.1090 – volume: 22 start-page: 1379 year: 2013 ident: B108 article-title: Striatal dopamine transmission is reduced after chronic nicotine with a decrease in α6-nicotinic receptor control in nucleus accumbens publication-title: Eur. J. Neurosci doi: 10.1111/ejn.12298 – volume: 27 start-page: 947 year: 2012 ident: B272 article-title: Nicotine as a potential neuroprotective agent for Parkinson's disease publication-title: Mov. Disord. Off. J. Mov. Disord. Soc doi: 10.1002/mds.25028 – volume: 45 start-page: 604 year: 1985 ident: B300 article-title: Biochemical characterization of the nicotinic cholinergic receptors in human brain: binding of (-)-[3H]nicotine publication-title: J. Neurochem doi: 10.1111/j.1471-4159.1985.tb04029.x – volume: 39 start-page: 2673 year: 2000 ident: B269 article-title: Characterization of nicotinic acetylcholine receptor-mediated [(3)H]-dopamine release from rat cortex and striatum publication-title: Neuropharmacology doi: 10.1016/S0028-3908(00)00131-3 – volume: 383 start-page: 713 year: 1996 ident: B133 article-title: Hippocampal synaptic transmission enhanced by low concentrations of nicotine publication-title: Nature doi: 10.1038/383713a0 – volume: 143 start-page: 119 year: 2004 ident: B294 article-title: P2X2 and P2Y1 immunofluorescence in rat neostriatal medium-spiny projection neurones and cholinergic interneurones is not linked to respective purinergic receptor function publication-title: Br. J. Pharmacol doi: 10.1038/sj.bjp.0705916 – volume: 97 start-page: 6 year: 1989 ident: B321 article-title: Tyrosine hydroxylase-like immunoreactive neurons in the striatum of the rat publication-title: Neurosci. Lett doi: 10.1016/0304-3940(89)90130-4 – volume: 556 start-page: 117 year: 1991 ident: B284 article-title: A post-mortem study on striatal dopamine receptors in Parkinson's disease publication-title: Brain Res doi: 10.1016/0006-8993(91)90554-9 – volume: 72 start-page: 195 year: 2004 ident: B11 article-title: Pathophysiology of obsessive-compulsive disorder: a necessary link between phenomenology, neuropsychology, imagery and physiology publication-title: Prog. Neurobiol doi: 10.1016/j.pneurobio.2004.02.004 – volume: 158 start-page: 97 year: 1999 ident: B52 article-title: Metabotropic glutamate receptors and cell-type-specific vulnerability in the striatum: implication for ischemia and Huntington's disease publication-title: Exp. Neurol doi: 10.1006/exnr.1999.7092 – volume: 33 start-page: 167 year: 2007b ident: B91 article-title: Differential localization of the GluR1 and GluR2 subunits of the AMPA-type glutamate receptor among striatal neuron types in rats publication-title: J. Chem. Neuroanat doi: 10.1016/j.jchemneu.2007.02.008 – volume: 23 start-page: 5272 year: 2003 ident: B260 article-title: Activation of beta1-adrenoceptors excites striatal cholinergic interneurons through a cAMP-dependent, protein kinase-independent pathway publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.23-12-05272.2003 – volume: 41 start-page: 1308 year: 2009 ident: B303 article-title: Genome-wide association study reveals genetic risk underlying Parkinson's disease publication-title: Nat. Genet doi: 10.1038/ng.487 – volume: 90 start-page: 803 year: 1999 ident: B305 article-title: m2 muscarinic receptor immunolocalization in cholinergic cells of the monkey basal forebrain and striatum publication-title: Neuroscience doi: 10.1016/S0306-4522(98)00527-2 – volume: 23 start-page: 747 year: 2012 ident: B78 article-title: The role of the basal ganglia in motivated behavior publication-title: Rev. Neurosci doi: 10.1515/revneuro-2012-0063 – volume: 81 start-page: 253 year: 2007 ident: B61 article-title: The corticostriatal pathway in Huntington's disease publication-title: Prog. Neurobiol doi: 10.1016/j.pneurobio.2006.11.001 – volume: 48 start-page: 545 year: 1992 ident: B240 article-title: Serotonin-, substance P- and glutamate/aspartate-like immunoreactivities in medullo-spinal pathways of rat and primate publication-title: Neuroscience doi: 10.1016/0306-4522(92)90401-M – volume: 27 start-page: 501 year: 2013b ident: B292 article-title: Apathy in Parkinson's disease: diagnosis, neuropsychological correlates, pathophysiology and treatment publication-title: Behav. Neurol doi: 10.3233/BEN-129025 – volume: 75 start-page: 205 year: 1987 ident: B101 article-title: Primate neostriatal neurons containing tyrosine hydroxylase: immunohistochemical evidence publication-title: Neurosci. Lett doi: 10.1016/0304-3940(87)90298-9 – volume: 67 start-page: 609 year: 1995 ident: B170 article-title: Ultrastructure of electrophysiologically-characterized synapses formed by serotonergic raphe neurons in culture publication-title: Neuroscience doi: 10.1016/0306-4522(95)00010-G – volume-title: An Essay on the Shaking Palsy year: 1817 ident: B247 – volume: 29 start-page: 1 year: 2005 ident: B74 article-title: Morphology and distribution of dopaminergic neurons intrinsic to the human striatum publication-title: J. Chem. Neuroanat doi: 10.1016/j.jchemneu.2004.08.007 – volume: 12 start-page: 3591 year: 1992 ident: B31 article-title: Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.12-09-03591.1992 – volume: 397 start-page: 279 year: 1986 ident: B41 article-title: Substance P-containing terminals in synaptic contact with cholinergic neurons in the neostriatum and basal forebrain: a double immunocytochemical study in the rat publication-title: Brain Res doi: 10.1016/0006-8993(86)90629-3 – volume: 79 start-page: 2568 year: 1998 ident: B340 article-title: Dopamine receptor-mediated mechanisms involved in the expression of learned activity of primate striatal neurons publication-title: J. Neurophysiol doi: 10.1152/jn.1998.79.5.2568 – volume: 8 start-page: 103 year: 2003 ident: B330 article-title: Mutational analysis of the nicotinic acetylcholine receptor alpha 4 subunit gene in attention deficit/hyperactivity disorder: evidence for association of an intronic polymorphism with attention problems publication-title: Mol. Psychiatry doi: 10.1038/sj.mp.4001257 – volume: 30 start-page: 62 year: 2007 ident: B14 article-title: Space, time and dopamine publication-title: Trends Neurosci doi: 10.1016/j.tins.2006.12.003 – volume: 355 start-page: 48 year: 1997 ident: B169 article-title: Adenosine A2A receptor stimulation increases release of acetylcholine from rat hippocampus but not striatum, and does not affect catecholamine release publication-title: Naunyn. Schmiedebergs Arch. Pharmacol doi: 10.1007/PL00004917 – volume: 7 start-page: 3915 year: 1987 ident: B120 article-title: The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.07-12-03915.1987 – volume: 71 start-page: 937 year: 1996 ident: B73 article-title: Ultrastructural characterization of the acetylcholine innervation in adult rat neostriatum publication-title: Neuroscience doi: 10.1016/0306-4522(95)00507-2 – volume: 98 start-page: 3388 year: 2007 ident: B178 article-title: Differential modulation by nicotine of substantia nigra versus ventral tegmental area dopamine neurons publication-title: J. Neurophysiol doi: 10.1152/jn.00760.2007 – volume: 95 start-page: 367 year: 2000 ident: B268 article-title: Tachykinins increase [3H]acetylcholine release in mouse striatum through multiple receptor subtypes publication-title: Neuroscience doi: 10.1016/S0306-4522(99)00440-6 – volume: 27 start-page: 482 year: 2006b ident: B127 article-title: Brain nicotinic acetylcholine receptors: native subtypes and their relevance publication-title: Trends Pharmacol. Sci doi: 10.1016/j.tips.2006.07.004 – volume: 1381 start-page: 228 year: 2011 ident: B328 article-title: GABA- and acetylcholine-related gene expression in blood correlate with tic severity and microarray evidence for alternative splicing in Tourette syndrome: a pilot study publication-title: Brain Res doi: 10.1016/j.brainres.2011.01.026 – volume: 14 start-page: 3351 year: 1994 ident: B152 article-title: Distribution of m1-m4 muscarinic receptor proteins in the rat striatum: light and electron microscopic immunocytochemistry using subtype-specific antibodies publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.14-05-03351.1994 – volume: 15 start-page: 458 year: 1995 ident: B158 article-title: Muscarinic receptors modulate N-, P-, and L-type Ca2+ currents in rat striatal neurons through parallel pathways publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.15-01-00458.1995 – volume: 25 start-page: 161 year: 2003 ident: B257 article-title: Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease publication-title: J. Chem. Neuroanat doi: 10.1016/S0891-0618(03)00002-4 – volume: 14 start-page: 1577 year: 2001 ident: B60 article-title: Differential sensitivity of medium- and large-sized striatal neurons to NMDA but not kainate receptor activation in the rat publication-title: Eur. J. Neurosci doi: 10.1046/j.0953-816x.2001.01783.x – volume: 127 start-page: 762 year: 2013 ident: B252 article-title: Long-term nicotine treatment down-regulates α6β 2* nicotinic receptor expression and function in nucleus accumbens publication-title: J. Neurochem doi: 10.1111/jnc.12442 – volume: 93 start-page: 2507 year: 2005 ident: B253 article-title: Cholinergic control of firing pattern and neurotransmission in rat neostriatal projection neurons: role of CaV2.1 and CaV2.2 Ca2+ channels publication-title: J. Neurophysiol doi: 10.1152/jn.00853.2004 – volume: 362 start-page: 79 year: 2004 ident: B171 article-title: Striatal tyrosine hydroxylase immunoreactive neurons are induced by L-dihydroxyphenylalanine and nerve growth factor treatment in 6-hydroxydopamine lesioned rats publication-title: Neurosci. Lett doi: 10.1016/j.neulet.2004.02.068 – volume: 108 start-page: 840 year: 2011b ident: B98 article-title: Enhanced striatal cholinergic neuronal activity mediates L-DOPA-induced dyskinesia in parkinsonian mice publication-title: Proc. Natl. Acad. Sci. U.S.A doi: 10.1073/pnas.1006511108 – volume: 84 start-page: 835 year: 2004 ident: B34 article-title: Molecular structure and physiological functions of GABA(B) receptors publication-title: Physiol. Rev doi: 10.1152/physrev.00036.2003 – volume: 21 start-page: 1452 year: 2001 ident: B181 article-title: Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.21-05-01452.2001 – volume: 80 start-page: 355 year: 1974 ident: B155 article-title: Decreased muscarinic receptor concentration in post-mortem brain in Huntington's chorea publication-title: Brain Res doi: 10.1016/0006-8993(74)90700-8 – volume: 74 start-page: 1416 year: 2010 ident: B121 article-title: Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes publication-title: Neurology doi: 10.1212/WNL.0b013e3181dc1a55 – volume: 15 start-page: 613 year: 2012 ident: B150 article-title: Structural correlates of heterogeneous in vivo activity of midbrain dopaminergic neurons publication-title: Nat. Neurosci doi: 10.1038/nn.3048 – volume: 30 start-page: 8229 year: 2010 ident: B313 article-title: Dopaminergic terminals in the nucleus accumbens but not the dorsal striatum corelease glutamate publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.1754-10.2010 – volume: 80 start-page: 1071 year: 2002 ident: B218 article-title: Direct evidence that release-stimulating alpha7* nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals publication-title: J. Neurochem doi: 10.1046/j.0022-3042.2002.00805.x – volume: 32 start-page: 1840 year: 2007 ident: B43 article-title: Endogenous serotonin excites striatal cholinergic interneurons via the activation of 5-HT 2C, 5-HT6, and 5-HT7 serotonin receptors: implications for extrapyramidal side effects of serotonin reuptake inhibitors publication-title: Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol doi: 10.1038/sj.npp.1301294 – volume: 106 start-page: 3019 year: 2011a ident: B97 article-title: Molecular and functional differences in voltage-activated sodium currents between GABA projection neurons and dopamine neurons in the substantia nigra publication-title: J. Neurophysiol doi: 10.1152/jn.00305.2011 – volume: 41 start-page: 495 year: 1991 ident: B139 article-title: K+ channel and 5-hydroxytryptamine1A autoreceptor interactions in the rat dorsal raphe nucleus: an in vitro electrophysiological study publication-title: Neuroscience doi: 10.1016/0306-4522(91)90344-N – volume: 220 start-page: 67 year: 1981 ident: B347 article-title: Spontaneous firing patterns of identified spiny neurons in the rat neostriatum publication-title: Brain Res doi: 10.1016/0006-8993(81)90211-0 – volume: 43 start-page: 586 year: 1998b ident: B53 article-title: Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: implications for ischemia and Huntington's disease publication-title: Ann. Neurol doi: 10.1002/ana.410430506 – volume: 75 start-page: 1263 year: 2010 ident: B69 article-title: Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease publication-title: Neurology doi: 10.1212/WNL.0b013e3181f6128c – volume: 248 start-page: 61 year: 1982 ident: B198 article-title: Muscarinic receptors on dopamine terminals in the cat caudate nucleus: neuromodulation of [3H]dopamine release in vitro by endogenous acetylcholine publication-title: Brain Res doi: 10.1016/0006-8993(82)91147-7 – volume: 83 start-page: 746 year: 2013 ident: B288 article-title: Ionotropic glutamate receptors: regulation by G-protein-coupled receptors publication-title: Mol. Pharmacol doi: 10.1124/mol.112.083352 – volume: 30 start-page: 228 year: 2007 ident: B316 article-title: D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons publication-title: Trends Neurosci doi: 10.1016/j.tins.2007.03.008 – volume: 16 start-page: 2279 year: 2002 ident: B92 article-title: Cholinergic modulation of nucleus accumbens medium spiny neurons publication-title: Eur. J. Neurosci doi: 10.1046/j.1460-9568.2002.02289.x – volume: 15 start-page: 7821 year: 1995 ident: B29 article-title: Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.15-12-07821.1995 – volume: 13 start-page: 2141 year: 2001 ident: B57 article-title: Presynaptic kynurenate-sensitive receptors inhibit glutamate release publication-title: Eur. J. Neurosci doi: 10.1046/j.0953-816x.2001.01592.x – volume: 8 start-page: 3750 year: 1988 ident: B214 article-title: Presynaptic actions of carbachol and adenosine on corticostriatal synaptic transmission studied in vitro publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.08-10-03750.1988 – volume: 223 start-page: 251 year: 2012 ident: B281 article-title: Effects of AZD3480, a neuronal nicotinic acetylcholine receptor agonist, and donepezil on dizocilpine-induced attentional impairment in rats publication-title: Psychopharmacology (Berl.) doi: 10.1007/s00213-012-2712-2 – volume: 116 start-page: 456 year: 1997 ident: B12 article-title: Responses of tonically discharging neurons in the monkey striatum to primary rewards delivered during different behavioral states publication-title: Exp. Brain Res doi: 10.1007/PL00005773 – volume: 21 start-page: 295 year: 1988 ident: B62 article-title: Dopamine-acetylcholine interaction in the rat striatum: a dual-labeling immunocytochemical study publication-title: Brain Res. Bull doi: 10.1016/0361-9230(88)90244-4 – volume: 13 start-page: 751 year: 1984 ident: B351 article-title: Cholinergic systems in the rat brain: I. projections to the limbic telencephalon publication-title: Brain Res. Bull doi: 10.1016/0361-9230(84)90236-3 – volume: 94 start-page: 21 year: 1999 ident: B156 article-title: Evidence for a deficit in cholinergic interneurons in the striatum in schizophrenia publication-title: Neuroscience doi: 10.1016/S0306-4522(99)00279-1 – volume: 24 start-page: 9870 year: 2004 ident: B280 article-title: Modulation of an afterhyperpolarization by the substantia nigra induces pauses in the tonic firing of striatal cholinergic interneurons publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.3225-04.2004 – volume: 308 start-page: 278 year: 1984 ident: B236 article-title: Kappa- and delta-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release publication-title: Nature doi: 10.1038/308278a0 – volume: 17 start-page: 204 year: 1997 ident: B128 article-title: Functional properties of AMPA and NMDA receptors expressed in identified types of basal ganglia neurons publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.17-01-00204.1997 – volume: 15 start-page: 5297 year: 1995 ident: B192 article-title: NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.15-07-05297.1995 – volume: 47 start-page: 557 year: 1996 ident: B54 article-title: A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices publication-title: Neurology doi: 10.1212/WNL.47.2.557 – volume: 191 start-page: 292 year: 2005 ident: B40 article-title: Cholinergic nicotinic receptor involvement in movement disorders associated with Lewy body diseases. An autoradiography study using [(125)I]alpha-conotoxinMII in the striatum and thalamus publication-title: Exp. Neurol doi: 10.1016/j.expneurol.2004.10.004 – volume: 59 start-page: 1085 year: 2002 ident: B202 article-title: Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia publication-title: Arch. Gen. Psychiatry doi: 10.1001/archpsyc.59.12.1085 – volume: 76 start-page: 409 year: 2003 ident: B147 article-title: Effects of donepezil on DOI-induced head twitch response in mice: implications for Tourette syndrome publication-title: Pharmacol. Biochem. Behav doi: 10.1016/j.pbb.2003.08.015 – volume: 20 start-page: 289 year: 2010 ident: B7 article-title: Evidence for association of the non-duplicated region of CHRNA7 gene with bipolar disorder but not with Schizophrenia publication-title: Psychiatr. Genet doi: 10.1097/YPG.0b013e32833a9b7a – volume: 299 start-page: 187 year: 1990 ident: B27 article-title: Organization of the thalamostriatal projections in the rat, with special emphasis on the ventral striatum publication-title: J. Comp. Neurol doi: 10.1002/cne.902990206 – volume: 18 start-page: 10207 year: 1998 ident: B30 article-title: Subcellular redistribution of m2 muscarinic acetylcholine receptors in striatal interneurons in vivo after acute cholinergic stimulation publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.18-23-10207.1998 – volume: 49 start-page: 166 year: 2001 ident: B81 article-title: Overview of nicotinic receptors and their roles in the central nervous system publication-title: Biol. Psychiatry doi: 10.1016/S0006-3223(00)01011-8 – volume: 10 start-page: 508 year: 1990 ident: B346 article-title: Firing patterns and synaptic potentials of identified giant aspiny interneurons in the rat neostriatum publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.10-02-00508.1990 – volume: 95 start-page: S91 year: 2000 ident: B285 article-title: The psychology and neurobiology of addiction: an incentive-sensitization view publication-title: Addict. Abingdon Engl doi: 10.1080/09652140050111681 – volume: 22 start-page: 143 year: 2006 ident: B256 article-title: Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons publication-title: Neurobiol. Dis doi: 10.1016/j.nbd.2005.10.009 – volume: 360 start-page: 552 year: 1999b ident: B267 article-title: Histaminergic neurons modulate acetylcholine release in the ventral striatum: role of H1 and H2 histamine receptors publication-title: Naunyn. Schmiedebergs Arch. Pharmacol doi: 10.1007/s002109900098 – volume: 116 start-page: 347 year: 1990 ident: B219 article-title: Muscarinic receptors mediate direct inhibition of GABA release from rat striatal nerve terminals publication-title: Neurosci. Lett doi: 10.1016/0304-3940(90)90099-U – volume: 60 start-page: 197 year: 1993 ident: B193 article-title: Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's disease publication-title: J. Neurochem doi: 10.1111/j.1471-4159.1993.tb05838.x – volume: 380 start-page: 593 year: 1986 ident: B100 article-title: Muscarinic slow excitation and muscarinic inhibition of synaptic transmission in the rat neostriatum publication-title: J. Physiol doi: 10.1113/jphysiol.1986.sp016304 – volume: 269 start-page: 1692 year: 1995 ident: B229 article-title: Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors publication-title: Science doi: 10.1126/science.7569895 – volume: 7 start-page: 581 year: 2004 ident: B359 article-title: Frequency-dependent modulation of dopamine release by nicotine publication-title: Nat. Neurosci doi: 10.1038/nn1243 – volume: 97 start-page: 457 year: 1974 ident: B35 article-title: Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia publication-title: Brain J. Neurol doi: 10.1093/brain/97.1.457 – volume: 63 start-page: 782 year: 2006 ident: B361 article-title: Early descriptions of Parkinson disease in ancient China publication-title: Arch. Neurol doi: 10.1001/archneur.63.5.782 – volume: 23 start-page: S28 year: 2000 ident: B307 article-title: Anatomy of the dopamine system in the basal ganglia publication-title: Trends Neurosci doi: 10.1016/S1471-1931(00)00023-9 – volume: 2 start-page: 33 year: 2012 ident: B49 article-title: Selective activation of cholinergic interneurons enhances accumbal phasic dopamine release: setting the tone for reward processing publication-title: Cell Rep doi: 10.1016/j.celrep.2012.05.011 – volume: 6 start-page: e19155 year: 2011 ident: B154 article-title: Cholinergic interneurons mediate fast VGluT3-dependent glutamatergic transmission in the striatum publication-title: PLoS ONE doi: 10.1371/journal.pone.0019155 – volume: 34 start-page: 8772 year: 2014a ident: B238 article-title: Striatal cholinergic neurotransmission requires VGLUT3 publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.0901-14.2014 – volume: 510(Pt 2) start-page: 441 year: 1998 ident: B197 article-title: Identification of an ATP-sensitive potassium channel current in rat striatal cholinergic interneurones publication-title: J. Physiol doi: 10.1111/j.1469-7793.1998.441bk.x – volume: 4 start-page: 2866 year: 1984 ident: B130 article-title: The control of firing pattern in nigral dopamine neurons: single spike firing publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.04-11-02866.1984 – volume: 9 start-page: 832 year: 2006 ident: B96 article-title: RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion publication-title: Nat. Neurosci doi: 10.1038/nn1700 – volume: 17 start-page: 819 year: 1997 ident: B32 article-title: Cellular, subcellular, and subsynaptic distribution of AMPA-type glutamate receptor subunits in the neostriatum of the rat publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.17-02-00819.1997 – volume: 780 start-page: 210 year: 1998 ident: B320 article-title: Localization of mGluR1a-like immunoreactivity and mGluR5-like immunoreactivity in identified populations of striatal neurons publication-title: Brain Res doi: 10.1016/S0006-8993(97)01141-4 – volume: 586 start-page: 265 year: 2008 ident: B114 article-title: Cell-specific spike-timing-dependent plasticity in GABAergic and cholinergic interneurons in corticostriatal rat brain slices publication-title: J. Physiol doi: 10.1113/jphysiol.2007.144501 – volume: 75 start-page: 78 year: 2013 ident: B263 article-title: Powerful inhibitory action of mu opioid receptors (MOR) on cholinergic interneuron excitability in the dorsal striatum publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2013.07.006 – volume: 115 start-page: 453 year: 2008 ident: B233 article-title: alpha-Synuclein pathology in the neostriatum in Parkinson's disease publication-title: Acta Neuropathol. (Berl.) doi: 10.1007/s00401-007-0316-4 – volume: 28 start-page: 8682 year: 2008 ident: B315 article-title: Recurrent inhibitory network among striatal cholinergic interneurons publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.2411-08.2008 – volume: 28 start-page: 11221 year: 2008 ident: B234 article-title: A dopaminergic axon lattice in the striatum and its relationship with cortical and thalamic terminals publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.2780-08.2008 – volume: 34 start-page: 4509 year: 2014 ident: B82 article-title: A major external source of cholinergic innervation of the striatum and nucleus accumbens originates in the brainstem publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.5071-13.2014 – volume: 608 start-page: 198 year: 1993 ident: B86 article-title: Differential effect of systemic administration of bromocriptine and L-dopa on the release of acetylcholine from striatum of intact and 6-OHDA-treated rats publication-title: Brain Res doi: 10.1016/0006-8993(93)91459-6 – volume: 28 start-page: 1672 year: 2008 ident: B46 article-title: Presynaptic opioid and nicotinic receptor modulation of dopamine overflow in the nucleus accumbens publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.4275-07.2008 – volume: 5 issue: 11 year: 2011 ident: B326 article-title: Dopamine signaling in dorsal versus ventral striatum: the dynamic role of cholinergic interneurons publication-title: Front. Syst. Neurosci doi: 10.3389/fnsys.2011.00011 – volume: 16 start-page: 5141 year: 1996 ident: B8 article-title: Actions of substance P on rat neostriatal neurons in vitro publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.16-16-05141.1996 – volume: 21 start-page: 1393 year: 2001 ident: B59 article-title: Stimulation of nitric oxide-cGMP pathway excites striatal cholinergic interneurons via protein kinase G activation publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.21-04-01393.2001 – volume: 25 start-page: 903 year: 1990 ident: B84 article-title: Muscarinic and dopaminergic receptor subtypes on striatal cholinergic interneurons publication-title: Brain Res. Bull doi: 10.1016/0361-9230(90)90186-4 – volume: 62 start-page: 70 year: 1994 ident: B87 article-title: GABAergic modulation of striatal cholinergic interneurons: an in vivo microdialysis study publication-title: J. Neurochem doi: 10.1046/j.1471-4159.1994.62010070.x – volume: 17 start-page: 5747 year: 1997 ident: B112 article-title: Influence of subunit composition on desensitization of neuronal acetylcholine receptors at low concentrations of nicotine publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.17-15-05747.1997 – volume: 30 start-page: 307 year: 2003 ident: B332 article-title: Molecular basis of opioid dependence: role of signal regulation by G-proteins publication-title: Clin. Exp. Pharmacol. Physiol doi: 10.1046/j.1440-1681.2003.03835.x – volume: 413 start-page: 179 year: 1987 ident: B186 article-title: Neostriatal cholinergic neurons receive direct synaptic inputs from dopaminergic axons publication-title: Brain Res doi: 10.1016/0006-8993(87)90167-3 – volume: 58 start-page: 529 year: 1992 ident: B17 article-title: Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases publication-title: J. Neurochem doi: 10.1111/j.1471-4159.1992.tb09752.x – volume: 22 start-page: 6347 year: 2002 ident: B360 article-title: Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1-M5 muscarinic receptor knock-out mice publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.22-15-06347.2002 – volume: 275 start-page: 213 year: 1997 ident: B220 article-title: Regulation of synaptic efficacy by coincidence of postsynaptic APs and EPSPs publication-title: Science doi: 10.1126/science.275.5297.213 – volume: 316 start-page: 481 year: 2006 ident: B271 article-title: Striatal alpha6* nicotinic acetylcholine receptors: potential targets for Parkinson's disease therapy publication-title: J. Pharmacol. Exp. Ther doi: 10.1124/jpet.105.094375 – volume: 189 start-page: 123 year: 1961 ident: B148 article-title: Gradient of choline acetylase activity publication-title: Nature doi: 10.1038/189123a0 – volume: 876 start-page: 124 year: 2000 ident: B287 article-title: Morphology and neurochemistry of two striatal neuronal subtypes expressing the GABA(A) receptor alpha3-subunit in the rat publication-title: Brain Res doi: 10.1016/S0006-8993(00)02636-6 – volume: 303 start-page: 633 year: 2002 ident: B187 article-title: Declines in different beta2* nicotinic receptor populations in monkey striatum after nigrostriatal damage publication-title: J. Pharmacol. Exp. Ther doi: 10.1124/jpet.102.039347 – volume: 1 start-page: 19 year: 2009 ident: B338 article-title: Polymorphisms in the neural nicotinic acetylcholine receptor α4 subunit (CHRNA4) are associated with ADHD in a genetic isolate publication-title: Atten. Deficit Hyperact. Disord doi: 10.1007/s12402-009-0003-5 – volume: 168 start-page: 395 year: 2010 ident: B166 article-title: Juxtacellular labeling of tonically active neurons and phasically active neurons in the rat striatum publication-title: Neuroscience doi: 10.1016/j.neuroscience.2010.03.062 – volume: 62 start-page: 635 year: 1994 ident: B200 article-title: Delta-opioid receptor gene expression in the mouse forebrain: localization in cholinergic neurons of the striatum publication-title: Neuroscience doi: 10.1016/0306-4522(94)90464-2 – volume: 7 start-page: 139 year: 1986 ident: B56 article-title: Bornaprine vs placebo in Parkinson disease: double-blind controlled cross-over trial in 30 patients publication-title: Ital. J. Neurol. Sci doi: 10.1007/BF02230432 – volume: 1 start-page: 54 year: 1996 ident: B85 article-title: The density of muscarinic M1 receptors is decreased in the caudate-putamen of subjects with schizophrenia publication-title: Mol. Psychiatry – volume: 247 start-page: 582 year: 2013 ident: B136 article-title: Dual effects of L-DOPA on nigral dopaminergic neurons publication-title: Exp. Neurol doi: 10.1016/j.expneurol.2013.02.009 – volume: 518 start-page: 277 year: 2010 ident: B175 article-title: Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome publication-title: J. Comp. Neurol doi: 10.1002/cne.22206 – volume: 20 start-page: 342 year: 2005 ident: B188 article-title: Levodopa-dyskinesia incidence by age of Parkinson's disease onset publication-title: Mov. Disord. Off. J. Mov. Disord. Soc doi: 10.1002/mds.20360 – volume: 81 start-page: 901 year: 2014 ident: B67 article-title: Dopamine neurons control striatal cholinergic neurons via regionally heterogeneous dopamine and glutamate signaling publication-title: Neuron doi: 10.1016/j.neuron.2013.12.027 – volume: 96 start-page: 95 year: 2011 ident: B93 article-title: Parallel associative processing in the dorsal striatum: segregation of stimulus-response and cognitive control subregions publication-title: Neurobiol. Learn. Mem doi: 10.1016/j.nlm.2011.06.002 – volume: 360 start-page: 558 year: 1999a ident: B266 article-title: Histaminergic neurons modulate acetylcholine release in the ventral striatum: role of H3 histamine receptors publication-title: Naunyn. Schmiedebergs Arch. Pharmacol doi: 10.1007/s002109900097 – volume: 342 start-page: 335 year: 2012 ident: B251 article-title: Long-term nicotine exposure depresses dopamine release in nonhuman primate nucleus accumbens publication-title: J. Pharmacol. Exp. Ther doi: 10.1124/jpet.112.194084 – volume: 14 start-page: 3005 year: 1994 ident: B323 article-title: Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.14-05-03005.1994 – volume: 333 start-page: 929 year: 2010 ident: B45 article-title: Nicotinic receptor-mediated reduction in L-DOPA-induced dyskinesias may occur via desensitization publication-title: J. Pharmacol. Exp. Ther doi: 10.1124/jpet.109.162396 – volume: 19 start-page: 3629 year: 1999 ident: B117 article-title: Cholinergic modulation of neostriatal output: a functional antagonism between different types of muscarinic receptors publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.19-09-03629.1999 – volume: 108 start-page: 433 year: 2009 ident: B352 article-title: Cholinergic modulation of angiogenesis: role of the 7 nicotinic acetylcholine receptor publication-title: J. Cell. Biochem doi: 10.1002/jcb.22270 – volume: 124 start-page: 203 year: 1986 ident: B296 article-title: Properties and roles of the three subclasses of histamine receptors in brain publication-title: J. Exp. Biol doi: 10.1242/jeb.124.1.203 – volume: 40 start-page: 460 year: 2001 ident: B259 article-title: Functional coexpression of excitatory mGluR1 and mGluR5 on striatal cholinergic interneurons publication-title: Neuropharmacology doi: 10.1016/S0028-3908(00)00184-2 – volume: 569 start-page: 715 year: 2005 ident: B39 article-title: Excitatory effects of serotonin on rat striatal cholinergic interneurones publication-title: J. Physiol doi: 10.1113/jphysiol.2005.098269 – volume: 39 start-page: 2756 year: 2000 ident: B115 article-title: Nicotinic receptors on hippocampal cultures can increase synaptic glutamate currents while decreasing the NMDA-receptor component publication-title: Neuropharmacology doi: 10.1016/S0028-3908(00)00102-7 – volume: 4 issue: 150 year: 2010 ident: B322 article-title: Heterogeneity and diversity of striatal GABAergic interneurons publication-title: Front. Neuroanat doi: 10.3389/fnana.2010.00150 – volume: 103 start-page: 1017 year: 2001 ident: B354 article-title: Coordinated expression of muscarinic receptor messenger RNAs in striatal medium spiny neurons publication-title: Neuroscience doi: 10.1016/S0306-4522(01)00039-2 – volume: 27 start-page: 468 year: 2004 ident: B335 article-title: Putting a spin on the dorsal-ventral divide of the striatum publication-title: Trends Neurosci doi: 10.1016/j.tins.2004.06.006 – volume: 43 start-page: 149 year: 1993 ident: B356 article-title: Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: distribution of m4 and m5 receptors in rat brain publication-title: Mol. Pharmacol doi: 10.1016/S0026-895X(25)13594-3 – volume: 34 start-page: 1319 year: 1977 ident: B228 article-title: Possible changes in striatal and limbic cholinergic systems in schizophrenia publication-title: Arch. Gen. Psychiatry doi: 10.1001/archpsyc.1977.01770230061003 – volume: 41 start-page: 202 year: 1991 ident: B184 article-title: Early development of levodopa-induced dyskinesias and response fluctuations in young-onset Parkinson's disease publication-title: Neurology doi: 10.1212/WNL.41.2_Part_1.202 – volume: 77 start-page: 1003 year: 1997 ident: B355 article-title: D2 dopamine receptors reduce N-type Ca2+ currents in rat neostriatal cholinergic interneurons through a membrane-delimited, protein-kinase-C-insensitive pathway publication-title: J. Neurophysiol doi: 10.1152/jn.1997.77.2.1003 – volume: 81 start-page: 4998 year: 1984 ident: B180 article-title: Tonically discharging putamen neurons exhibit set-dependent responses publication-title: Proc. Natl. Acad. Sci. U.S.A doi: 10.1073/pnas.81.15.4998 – volume: 7 start-page: 53 year: 2008 ident: B196 article-title: Association study of the nicotinic acetylcholine receptor alpha4 subunit gene, CHRNA4, in attention-deficit hyperactivity disorder publication-title: Genes Brain Behav doi: 10.1111/j.1601-183X.2007.00325.x – volume: 347 start-page: 225 year: 2013 ident: B358 article-title: Nicotinic receptor agonists reduce L-DOPA-induced dyskinesias in a monkey model of Parkinson's disease publication-title: J. Pharmacol. Exp. Ther doi: 10.1124/jpet.113.207639 – volume: 591 start-page: 203 year: 2013 ident: B210 article-title: Direct and GABA-mediated indirect effects of nicotinic ACh receptor agonists on striatal neurones publication-title: J. Physiol doi: 10.1113/jphysiol.2012.241786 – volume: 122 start-page: 520 year: 1997 ident: B295 article-title: Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum publication-title: Br. J. Pharmacol doi: 10.1038/sj.bjp.0701394 – volume: 521 start-page: 2502 year: 2013 ident: B125 article-title: GABAergic inputs from direct and indirect striatal projection neurons onto cholinergic interneurons in the primate putamen publication-title: J. Comp. Neurol doi: 10.1002/cne.23295 – volume: 80 start-page: 257 year: 2003 ident: B277 article-title: Acetylcholine actions in the dorsomedial striatum support the flexible shifting of response patterns publication-title: Neurobiol. Learn. Mem doi: 10.1016/S1074-7427(03)00077-7 – volume: 7 start-page: 583 year: 2004 ident: B282 article-title: Nicotine amplifies reward-related dopamine signals in striatum publication-title: Nat. Neurosci doi: 10.1038/nn1244 – volume: 22 start-page: 443 year: 1999 ident: B211 article-title: Presynaptic ionotropic receptors and the control of transmitter release publication-title: Annu. Rev. Neurosci doi: 10.1146/annurev.neuro.22.1.443 – volume: 1 start-page: a008862 year: 2011 ident: B123 article-title: The history of Parkinson's disease: early clinical descriptions and neurological therapies publication-title: Cold Spring Harb. Perspect. Med doi: 10.1101/cshperspect.a008862 – volume: 39 start-page: 2715 year: 2000 ident: B122 article-title: Facilitation of glutamatergic neurotransmission by presynaptic nicotinic acetylcholine receptors publication-title: Neuropharmacology doi: 10.1016/S0028-3908(00)00145-3 – volume: 405 start-page: 450 year: 1999 ident: B222 article-title: Differential distribution of endomorphin 1- and endomorphin 2-like immunoreactivities in the CNS of the rodent publication-title: J. Comp. Neurol doi: 10.1002/(SICI)1096-9861(19990322)405:4<450::AID-CNE2>3.0.CO;2-# – volume: 15 start-page: 3119 year: 2006 ident: B306 article-title: Cholinergic neuronal defect without cell loss in Huntington's disease publication-title: Hum. Mol. Genet doi: 10.1093/hmg/ddl252 – volume: 22 start-page: 1379 year: 2007 ident: B109 article-title: Levodopa-induced dyskinesias publication-title: Mov. Disord. Off. J. Mov. Disord. Soc doi: 10.1002/mds.21475 – volume: 116 start-page: 531 year: 1976a ident: B106 article-title: Alterations of brain neurotransmitter receptor binding in Huntington's chorea publication-title: Brain Res doi: 10.1016/0006-8993(76)90502-3 – volume: 88 start-page: 1183 year: 2008 ident: B137 article-title: Histamine in the nervous system publication-title: Physiol. Rev doi: 10.1152/physrev.00043.2007 – volume: 16 start-page: 309 year: 2010 ident: B275 article-title: Treating the cognitive deficits of schizophrenia with alpha4beta2 neuronal nicotinic receptor agonists publication-title: Curr. Pharm. Des doi: 10.2174/138161210790170166 – volume: 46 start-page: 351 year: 1992 ident: B337 article-title: Ultrastructural relationships between choline acetyltransferase- and neuropeptide y-containing neurons in the rat striatum publication-title: Neuroscience doi: 10.1016/0306-4522(92)90057-9 – volume: 73 start-page: 19 year: 2006 ident: B66 article-title: Functions of frontostriatal systems in cognition: comparative neuropsychopharmacological studies in rats, monkeys and humans publication-title: Biol. Psychol doi: 10.1016/j.biopsycho.2006.01.005 – volume: 12 start-page: 711 year: 1984 ident: B42 article-title: Characterization of cholinergic neurons in the rat neostriatum. A combination of choline acetyltransferase immunocytochemistry, Golgi-impregnation and electron microscopy publication-title: Neuroscience doi: 10.1016/0306-4522(84)90165-9 – volume: 6 start-page: 787 year: 2005 ident: B72 article-title: Metabotropic glutamate receptors in the basal ganglia motor circuit publication-title: Nat. Rev. Neurosci doi: 10.1038/nrn1763 – volume: 75 start-page: 58 year: 2012 ident: B327 article-title: Striatal dopamine release is triggered by synchronized activity in cholinergic interneurons publication-title: Neuron doi: 10.1016/j.neuron.2012.04.038 – volume: 38 start-page: 405 year: 2013 ident: B20 article-title: A randomized, double-blind, placebo-controlled phase 2 study of α4β2 agonist ABT-894 in adults with ADHD publication-title: Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol doi: 10.1038/npp.2012.194 – volume: 42 start-page: 1933 year: 1988 ident: B83 article-title: Evidence for dopamine D-2 receptors on cholinergic interneurons in the rat caudate-putamen publication-title: Life Sci doi: 10.1016/0024-3205(88)90492-4 – volume: 27 start-page: 8845 year: 2007 ident: B28 article-title: TrpC3/C7 and Slo2.1 are molecular targets for metabotropic glutamate receptor signaling in rat striatal cholinergic interneurons publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.0551-07.2007 – volume: 12 start-page: 2871 year: 2000 ident: B336 article-title: Differential modulation of AMPA receptors by cyclothiazide in two types of striatal neurons publication-title: Eur. J. Neurosci doi: 10.1046/j.1460-9568.2000.00175.x – volume: 95 start-page: 501 year: 2010 ident: B194 article-title: Chapter 33: the history of movement disorders publication-title: Handb. Clin. Neurol doi: 10.1016/S0072-9752(08)02133-7 – volume: 99 start-page: 436 year: 1941 ident: B212 article-title: The distribution of acetylcholine in the peripheral and the central nervous system publication-title: J. Physiol doi: 10.1113/jphysiol.1941.sp003913 – volume: 102 start-page: 518 year: 1991 ident: B235 article-title: Pharmacological profile of various kappa-agonists at kappa-, mu- and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain publication-title: Br. J. Pharmacol doi: 10.1111/j.1476-5381.1991.tb12203.x – volume: 9 start-page: 689 year: 1994 ident: B207 article-title: Anticholinergics and dyskinesia publication-title: Mov. Disord. Off. J. Mov. Disord. Soc doi: 10.1002/mds.870090618 – volume: 68 start-page: 1942 year: 1997 ident: B308 article-title: Muscarinic modulation of striatal dopamine, glutamate, and GABA release, as measured with in vivo microdialysis publication-title: J. Neurochem doi: 10.1046/j.1471-4159.1997.68051942.x – volume: 567 start-page: 313 year: 1991 ident: B290 article-title: Effect of nicotine on dopaminergic-cholinergic interaction in the striatum publication-title: Brain Res doi: 10.1016/0006-8993(91)90810-I – volume: 10 start-page: 69 year: 1996 ident: B342 article-title: Molecular biology of muscarinic acetylcholine receptors publication-title: Crit. Rev. Neurobiol doi: 10.1615/CritRevNeurobiol.v10.i1.40 – volume: 64 start-page: 11 year: 1999 ident: B310 article-title: Expression of NMDA glutamate receptor subunit mRNAs in neurochemically identified projection and interneurons in the striatum of the rat publication-title: Brain Res. Mol. Brain Res doi: 10.1016/S0169-328X(98)00293-9 – volume: 27 start-page: 3148 year: 2007a ident: B90 article-title: Involvement of I(h) in dopamine modulation of tonic firing in striatal cholinergic interneurons publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.5535-06.2007 – volume: 21 start-page: 1347 year: 1996 ident: B76 article-title: Modulatory effects of Gs-coupled excitatory opioid receptor functions on opioid analgesia, tolerance, and dependence publication-title: Neurochem. Res doi: 10.1007/BF02532375 – volume: 21 start-page: 6492 year: 2001b ident: B318 article-title: Dopamine-dependent synaptic plasticity in the striatal cholinergic interneurons publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.21-17-06492.2001 – volume: 41 start-page: 318 year: 1910 ident: B80 article-title: The physiological action of beta-iminazolylethylamine publication-title: J. Physiol doi: 10.1113/jphysiol.1910.sp001406 – volume: 91 start-page: 891 year: 1999 ident: B226 article-title: Three-dimensional distribution of nigrostriatal neurons in the rat: relation to the topography of striatonigral projections publication-title: Neuroscience doi: 10.1016/S0306-4522(98)00681-2 – volume: 277 start-page: 359 year: 1996 ident: B71 article-title: Both dynorphin A(1-17) and [Des-Tyr1]dynorphin A(2-17) inhibit adenylyl cyclase activity in rat caudate putamen publication-title: J. Pharmacol. Exp. Ther doi: 10.1016/S0022-3565(25)12831-0 – volume: 75 start-page: 207 year: 2014 ident: B264 article-title: AZD3480, a novel nicotinic receptor agonist, for the treatment of attention-deficit/hyperactivity disorder in adults publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2013.06.002 – volume: 51 start-page: 533 year: 1992 ident: B195 article-title: Input from the frontal cortex and the parafascicular nucleus to cholinergic interneurons in the dorsal striatum of the rat publication-title: Neuroscience doi: 10.1016/0306-4522(92)90293-B – start-page: CD003735 year: 2003 ident: B176 article-title: Anticholinergics for symptomatic management of Parkinson's disease publication-title: Cochrane Database Syst. Rev doi: 10.1002/14651858.CD003735 – volume: 88 start-page: 2608 year: 1991 ident: B314 article-title: Distinct muscarinic receptors inhibit release of gamma-aminobutyric acid and excitatory amino acids in mammalian brain publication-title: Proc. Natl. Acad. Sci. U.S.A doi: 10.1073/pnas.88.6.2608 – volume: 41 start-page: 329 year: 2001a ident: B317 article-title: Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers publication-title: Synapse doi: 10.1002/syn.1089 – volume: 408 start-page: 584 year: 2000 ident: B241 article-title: Calcium stores regulate the polarity and input specificity of synaptic modification publication-title: Nature doi: 10.1038/35046067 – volume: 60 start-page: 211 year: 1994 ident: B144 article-title: Differential effects of lesions of the dorsomedial and dorsolateral caudate-putamen on reaction time performance in rats publication-title: Behav. Brain Res doi: 10.1016/0166-4328(94)90149-X – volume: 1 start-page: 433 year: 2002 ident: B227 article-title: The importance of nicotinic acetylcholine receptors in schizophrenia, bipolar disorder and Tourette's syndrome publication-title: Curr. Drug Targets CNS Neurol. Disord doi: 10.2174/1568007023339210 – volume: 522 start-page: 2465 year: 2014 ident: B343 article-title: Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodents publication-title: J. Comp. Neurol doi: 10.1002/cne.23583 – volume: 88 start-page: 195 year: 1975 ident: B190 article-title: Bilateral projections from precentral motor cortex to the putamen and other parts of the basal ganglia. An autoradiographic study in Macaca fascicularis publication-title: Brain Res doi: 10.1016/0006-8993(75)90384-4 – volume: 8 start-page: 2428 year: 1996 ident: B201 article-title: Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain publication-title: Eur. J. Neurosci doi: 10.1111/j.1460-9568.1996.tb01206.x – volume: 81 start-page: 142 year: 2002 ident: B26 article-title: Functional and molecular characterization of metabotropic glutamate receptors expressed in rat striatal cholinergic interneurones publication-title: J. Neurochem doi: 10.1046/j.1471-4159.2002.00815.x – volume: 350 start-page: 412 year: 1994 ident: B215 article-title: Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study publication-title: J. Comp. Neurol doi: 10.1002/cne.903500307 – volume: 25 start-page: 7449 year: 2005 ident: B298 article-title: Cholinergic suppression of KCNQ channel currents enhances excitability of striatal medium spiny neurons publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.1381-05.2005 – volume: 74 start-page: 1212 year: 2007 ident: B345 article-title: Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition publication-title: Biochem. Pharmacol doi: 10.1016/j.bcp.2007.07.002 – volume: 255 start-page: 154 year: 2014 ident: B111 article-title: Allosteric modulation of NMDA receptors alters neurotransmission in the striatum of a mouse model of Parkinson's disease publication-title: Exp. Neurol doi: 10.1016/j.expneurol.2014.03.001 – volume: 63 start-page: 938 year: 2011 ident: B274 article-title: α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease publication-title: Pharmacol. Rev doi: 10.1124/pr.110.003269 – volume: 23 start-page: 481 year: 2006a ident: B126 article-title: Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation publication-title: Neurobiol. Dis doi: 10.1016/j.nbd.2006.04.005 – volume: 96 start-page: 1581 year: 2006 ident: B363 article-title: Opposite functions of histamine H1 and H2 receptors and H3 receptor in substantia nigra pars reticulata publication-title: J. Neurophysiol doi: 10.1152/jn.00148.2006 – volume: 63 start-page: 182 year: 2011 ident: B23 article-title: The physiology, signaling, and pharmacology of dopamine receptors publication-title: Pharmacol. Rev doi: 10.1124/pr.110.002642 – volume: 263 start-page: 138 year: 2014 ident: B293 article-title: GABAergic synaptic transmission onto striatal cholinergic interneurons in dopamine D2 receptor knock-out mice publication-title: Neuroscience doi: 10.1016/j.neuroscience.2014.01.010 – volume: 490 start-page: 262 year: 2012 ident: B331 article-title: Dopaminergic neurons inhibit striatal output through non-canonical release of GABA publication-title: Nature doi: 10.1038/nature11466 – volume: 17 start-page: 165 year: 2000 ident: B159 article-title: Early Parkinson's disease: what is the best approach to treatment publication-title: Drugs Aging doi: 10.2165/00002512-200017030-00002 – volume: 393 start-page: 51 year: 2000 ident: B349 article-title: Presynaptic nicotinic receptors modulating dopamine release in the rat striatum publication-title: Eur. J. Pharmacol doi: 10.1016/S0014-2999(00)00005-4 – volume: 594 start-page: 253 year: 1992 ident: B223 article-title: Ultrastructural examination of enkephalin and substance P input to cholinergic neurons within the rat neostriatum publication-title: Brain Res doi: 10.1016/0006-8993(92)91132-X – volume: 20 start-page: 2783 year: 2000 ident: B297 article-title: UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.20-08-02783.2000 – volume: 30 start-page: 2951 year: 2010 ident: B299 article-title: Acquisition and performance of goal-directed instrumental actions depends on ERK signaling in distinct regions of dorsal striatum in rats publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.1778-09.2010 – volume: 654 start-page: 171 year: 1992 ident: B182 article-title: Neural mechanisms of drug reinforcement publication-title: Ann. N.Y. Acad. Sci doi: 10.1111/j.1749-6632.1992.tb25966.x – volume: 30 start-page: 14719 year: 2010 ident: B357 article-title: The sensorimotor striatum is necessary for serial order learning publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.3989-10.2010 – volume: 74 start-page: 839 year: 2000 ident: B283 article-title: Correlating physiology with gene expression in striatal cholinergic neurones publication-title: J. Neurochem doi: 10.1046/j.1471-4159.2000.740839.x – volume: 33 start-page: 1678 year: 2013 ident: B319 article-title: Target selectivity of feedforward inhibition by striatal fast-spiking interneurons publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.3572-12.2013 – volume: 8 start-page: 512 year: 1993 ident: B145 article-title: Orobuccal dyskinesia associated with trihexyphenidyl therapy in a patient with Parkinson's disease publication-title: Mov. Disord. Off. J. Mov. Disord. Soc doi: 10.1002/mds.870080417 – volume: 29 start-page: 444 year: 2009 ident: B225 article-title: Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.4029-08.2009 – volume: 21 start-page: 1081 year: 2011 ident: B311 article-title: Evolutionary conservation of the basal ganglia as a common vertebrate mechanism for action selection publication-title: Curr. Biol doi: 10.1016/j.cub.2011.05.001 – volume: 348 start-page: 234 year: 1993 ident: B168 article-title: No evidence for presynaptic opioid receptors on cholinergic, but presence of kappa-receptors on dopaminergic neurons in the rabbit caudate nucleus: involvement of endogenous opioids publication-title: Naunyn. Schmiedebergs Arch. Pharmacol doi: 10.1007/BF00169150 – volume: 160 start-page: 118 year: 2003 ident: B276 article-title: In vivo determination of muscarinic acetylcholine receptor availability in schizophrenia publication-title: Am. J. Psychiatry doi: 10.1176/appi.ajp.160.1.118 – volume: 50 start-page: 1111 year: 1988 ident: B140 article-title: Acetylcholinesterase in Huntington's and Alzheimer's diseases: simultaneous enzyme assay and immunoassay of multiple brain regions publication-title: J. Neurochem doi: 10.1111/j.1471-4159.1988.tb10580.x – volume: 439 start-page: 235 year: 2001 ident: B172 article-title: Presynaptic localisation of the nicotinic acetylcholine receptor beta2 subunit immunoreactivity in rat nigrostriatal dopaminergic neurones publication-title: J. Comp. Neurol doi: 10.1002/cne.1345 – volume: 523 start-page: 51 year: 1990 ident: B16 article-title: Effect of opioids on acetylcholine release evoked by K+ or glutamic acid from rat neostriatal slices publication-title: Brain Res doi: 10.1016/0006-8993(90)91633-R – volume: 110 start-page: 2325 year: 2013 ident: B261 article-title: Regulation of dendritic calcium release in striatal spiny projection neurons publication-title: J. Neurophysiol doi: 10.1152/jn.00422.2013 – volume: 114 start-page: 154 year: 1990 ident: B333 article-title: Localization of m5 muscarinic receptor mRNA in rat brain examined by in situ hybridization histochemistry publication-title: Neurosci. Lett doi: 10.1016/0304-3940(90)90064-G – volume: 131 start-page: 1135 year: 2000 ident: B25 article-title: Histamine depolarizes cholinergic interneurones in the rat striatum via a H(1)-receptor mediated action publication-title: Br. J. Pharmacol doi: 10.1038/sj.bjp.0703692 – volume: 4 issue: 131 year: 2010 ident: B21 article-title: Basal Ganglia circuits underlying the pathophysiology of levodopa-induced dyskinesia publication-title: Front. Neuroanat doi: 10.3389/fnana.2010.00131 – volume: 326 start-page: 193 year: 1992 ident: B255 article-title: Comparative molecular neuroanatomy of cloned GABAA receptor subunits in the rat CNS publication-title: J. Comp. Neurol doi: 10.1002/cne.903260204 – volume: 28 start-page: 566 year: 2013 ident: B243 article-title: The history of parkinsonism: descriptions in ancient Indian medical literature publication-title: Mov. Disord. Off. J. Mov. Disord. Soc doi: 10.1002/mds.25420 – volume: 87 start-page: 7050 year: 1990 ident: B341 article-title: Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia publication-title: Proc. Natl. Acad. Sci. U.S.A doi: 10.1073/pnas.87.18.7050 – volume: 615 start-page: 91 year: 2009 ident: B189 article-title: Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations publication-title: Eur. J. Pharmacol doi: 10.1016/j.ejphar.2009.04.058 – volume: 294 start-page: 1305 year: 1976b ident: B107 article-title: Huntington's chorea. Changes in neurotransmitter receptors in the brain publication-title: N. Engl. J. Med doi: 10.1056/NEJM197606102942402 – volume: 15 start-page: 65 year: 2004 ident: B5 article-title: Parkinson's disease protects against smoking? publication-title: Behav. Neurol doi: 10.1155/2004/516302 – volume: 35 start-page: 2179 year: 2014 ident: B22 article-title: CHRNB3 c.-57A>G functional promoter change affects Parkinson's disease and smoking publication-title: Neurobiol. Aging doi: 10.1016/j.neurobiolaging.2014.03.014 – volume: 17 start-page: 1940 year: 1997 ident: B50 article-title: Opposite membrane potential changes induced by glucose deprivation in striatal spiny neurons and in large aspiny interneurons publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.17-06-01940.1997 – volume: 3 start-page: 241 year: 2013 ident: B103 article-title: Review: electrophysiology of basal ganglia and cortex in models of Parkinson disease publication-title: J. Park. Dis doi: 10.3233/JPD-130204 – volume: 79 start-page: 28 year: 2012 ident: B113 article-title: Updates in the medical management of Parkinson disease publication-title: Cleve. Clin. J. Med doi: 10.3949/ccjm.78gr.11005 – volume: 11 start-page: 292 year: 2008 ident: B132 article-title: The vesicular glutamate transporter VGLUT3 synergizes striatal acetylcholine tone publication-title: Nat. Neurosci doi: 10.1038/nn2052 – volume: 50 start-page: 801 year: 1974 ident: B37 article-title: Abnormal involuntary movements induced by anticholinergic therapy publication-title: Acta Neurol. Scand doi: 10.1111/j.1600-0404.1974.tb02820.x – volume: 143 start-page: 195 year: 1987 ident: B165 article-title: Pertussis toxin blocks 5-HT1A and GABAB receptor-mediated inhibition of serotonergic neurons publication-title: Eur. J. Pharmacol doi: 10.1016/0014-2999(87)90533-4 – volume: 8 start-page: 135 year: 1992 ident: B237 article-title: Calcium influx through nicotinic receptor in rat central neurons: its relevance to cellular regulation publication-title: Neuron doi: 10.1016/0896-6273(92)90115-T – volume: 38 start-page: 290 year: 1996 ident: B301 article-title: Transdermal nicotine for Tourette's syndrome publication-title: Drug Dev. Res doi: 10.1002/(SICI)1098-2299(199607/08)38:3/4290::AID-DDR183.0.CO;2-2 – volume: 13 start-page: 281 year: 1990 ident: B89 article-title: Primate models of movement disorders of basal ganglia origin publication-title: Trends Neurosci doi: 10.1016/0166-2236(90)90110-V – volume: 45 start-page: 1041 year: 1995 ident: B232 article-title: Cigarette smoking and protection from Parkinson's disease: false association or etiologic clue? publication-title: Neurology doi: 10.1212/WNL.45.6.1041 – volume: 12 start-page: 366 year: 1989 ident: B3 article-title: The functional anatomy of basal ganglia disorders publication-title: Trends Neurosci doi: 10.1016/0166-2236(89)90074-X – volume: 130 start-page: 222 year: 2007 ident: B162 article-title: The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea publication-title: Brain J. Neurol doi: 10.1093/brain/awl332 – volume: 98 start-page: 581 year: 2007 ident: B209 article-title: Action-potential-independent GABAergic tone mediated by nicotinic stimulation of immature striatal miniature synaptic transmission publication-title: J. Neurophysiol doi: 10.1152/jn.00768.2006 – volume: 17 start-page: 8498 year: 1997 ident: B1 article-title: Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.17-21-08498.1997 – volume: 81 start-page: 2572 year: 1984 ident: B246 article-title: Histamine-containing neurons in the rat hypothalamus publication-title: Proc. Natl. Acad. Sci. U.S.A doi: 10.1073/pnas.81.8.2572 – volume: 37 start-page: 252 year: 2000 ident: B324 article-title: Cortical inputs to m2-immunoreactive striatal interneurons in rat and monkey publication-title: Synapse doi: 10.1002/1098-2396(20000915)37:4252::AID-SYN23.0.CO;2-A – volume: 11 start-page: 2332 year: 1991 ident: B15 article-title: Neurokinin receptors differentially mediate endogenous acetylcholine release evoked by tachykinins in the neostriatum publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.11-08-02332.1991 – volume: 10 start-page: 508 year: 2013 ident: B70 article-title: CLARITY for mapping the nervous system publication-title: Nat. Methods doi: 10.1038/nmeth.2481 – volume: 23 start-page: 6245 year: 2003 ident: B58 article-title: Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.23-15-06245.2003 – volume: 87 start-page: 7025 year: 1990 ident: B134 article-title: Dynorphin A and cAMP-dependent protein kinase independently regulate neuronal calcium currents publication-title: Proc. Natl. Acad. Sci. U.S.A doi: 10.1073/pnas.87.18.7025 – volume: 37 start-page: 1493 year: 1998 ident: B151 article-title: 3-Alpha-chloro-imperialine, a potent blocker of cholinergic presynaptic modulation of glutamatergic afferents in the rat neostriatum publication-title: Neuropharmacology doi: 10.1016/S0028-3908(98)00131-2 – volume: 74 start-page: 1224 year: 2007 ident: B270 article-title: Nicotinic receptors as CNS targets for Parkinson's disease publication-title: Biochem. Pharmacol doi: 10.1016/j.bcp.2007.06.015 – volume: 14 start-page: 546 year: 2009 ident: B135 article-title: A high-density single-nucleotide polymorphism screen of 23 candidate genes in attention deficit hyperactivity disorder: suggesting multiple susceptibility genes among Chinese Han population publication-title: Mol. Psychiatry doi: 10.1038/sj.mp.4002139 – volume: 74 start-page: 1235 year: 2007 ident: B131 article-title: The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum publication-title: Biochem. Pharmacol doi: 10.1016/j.bcp.2007.07.032 – volume: 27 start-page: 460 year: 2004 ident: B213 article-title: Corticostriatal plasticity: life after the depression publication-title: Trends Neurosci doi: 10.1016/j.tins.2004.06.010 – volume: 73 start-page: 715 year: 1996 ident: B65 article-title: Cellular expression of ionotropic glutamate receptor subunits on specific striatal neuron types and its implication for striatal vulnerability in glutamate receptor-mediated excitotoxicity publication-title: Neuroscience doi: 10.1016/0306-4522(96)00011-5 – volume: 2 start-page: 1157 year: 1977 ident: B36 article-title: Increased brain dopamine and reduced glutamic acid decarboxylase and choline acetyl transferase activity in schizophrenia and related psychoses publication-title: Lancet doi: 10.1016/S0140-6736(77)91542-2 – volume: 17 start-page: 6761 year: 1997 ident: B33 article-title: Dopaminergic neurons intrinsic to the primate striatum publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.17-17-06761.1997 – volume: 355 start-page: 69 year: 2004 ident: B157 article-title: Association study of the human partially duplicated alpha7 nicotinic acetylcholine receptor genetic variant with bipolar disorder publication-title: Neurosci. Lett doi: 10.1016/j.neulet.2003.10.043 – volume: 10 start-page: 1105 year: 1983 ident: B199 article-title: The striatal cholinergic interneuron: synaptic target of dopaminergic terminals? publication-title: Neuroscience doi: 10.1016/0306-4522(83)90102-1 – volume: 86 start-page: 429 year: 2001 ident: B224 article-title: Excitation of rat striatal large neurons by dopamine and/or glutamate released from nerve terminals via presynaptic nicotinic receptor (A4beta2 type) stimulation publication-title: Jpn. J. Pharmacol doi: 10.1254/jjp.86.429 – volume: 20 start-page: 2369 year: 2000 ident: B138 article-title: Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum publication-title: J. Neurosci doi: 10.0270-6474/00/202369-14 – volume: 16 start-page: 418 year: 1993 ident: B124 article-title: Effect of nondopaminergic drugs on L-dopa-induced dyskinesias in MPTP-treated monkeys publication-title: Clin. Neuropharmacol doi: 10.1097/00002826-199310000-00004 – volume: 114 start-page: 1308 year: 2012 ident: B19 article-title: Anti-cholinergics for axial symptoms in Parkinson's disease after subthalamic stimulation publication-title: Clin. Neurol. Neurosurg doi: 10.1016/j.clineuro.2012.03.046 – volume: 34 start-page: 8557 year: 2014 ident: B312 article-title: Multiphasic modulation of cholinergic interneurons by nigrostriatal afferents publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.0589-14.2014 – volume: 309 start-page: 391 year: 1991 ident: B143 article-title: Single dopaminergic nigrostriatal neurons form two chemically distinct synaptic types: possible transmitter segregation within neurons publication-title: J. Comp. Neurol doi: 10.1002/cne.903090308 – volume: 287 start-page: 109 year: 2000 ident: B102 article-title: Human post-mortem striatal alpha4beta2 nicotinic acetylcholine receptor density in schizophrenia and Parkinson's syndrome publication-title: Neurosci. Lett doi: 10.1016/S0304-3940(00)01144-7 – volume: 56 start-page: 850 year: 2010 ident: B55 article-title: In vivo modulation of alpha7 nicotinic receptors on striatal glutamate release induced by anatoxin-A publication-title: Neurochem. Int doi: 10.1016/j.neuint.2010.03.010 – volume: 15 start-page: 123 year: 2011 ident: B105 article-title: Novel GABAergic circuits mediate the reinforcement-related signals of striatal cholinergic interneurons publication-title: Nat. Neurosci doi: 10.1038/nn.2984 – volume: 11 start-page: 3218 year: 1991 ident: B204 article-title: Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.11-10-03218.1991 – volume: 22 start-page: 6176 year: 2002 ident: B258 article-title: Metabotropic glutamate 2 receptors modulate synaptic inputs and calcium signals in striatal cholinergic interneurons publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.22-14-06176.2002 – volume: 85 start-page: 491 year: 1991 ident: B13 article-title: Responses to reward in monkey dorsal and ventral striatum publication-title: Exp. Brain Res doi: 10.1007/BF00231732 – volume: 8 start-page: 1140 year: 2009 ident: B334 article-title: Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders publication-title: Lancet Neurol doi: 10.1016/S1474-4422(09)70287-X – volume: 285 start-page: 1725 year: 1999 ident: B339 article-title: Activity-induced potentiation of developing neuromuscular synapses publication-title: Science doi: 10.1126/science.285.5434.1725 – volume: 14 start-page: 3969 year: 1994 ident: B10 article-title: Responses of tonically active neurons in the primate's striatum undergo systematic changes during behavioral sensorimotor conditioning publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.14-06-03969.1994 – volume: 67 start-page: 294 year: 2010 ident: B95 article-title: Thalamic gating of corticostriatal signaling by cholinergic interneurons publication-title: Neuron doi: 10.1016/j.neuron.2010.06.017 – volume: 5 start-page: 47 year: 1990 ident: B216 article-title: Paralysis agitans and levodopa in “Ayurvedaâ€: ancient Indian medical treatise publication-title: Mov. Disord. Off. J. Mov. Disord. Soc doi: 10.1002/mds.870050112 – volume: 19 start-page: 4682 year: 1999 ident: B286 article-title: Electrophysiological and morphological evidence for a GABAergic nigrostriatal pathway publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.19-11-04682.1999 – volume: 31 start-page: 1183 year: 2011 ident: B68 article-title: Functional connectome of the striatal medium spiny neuron publication-title: J. Neurosci doi: 10.1523/JNEUROSCI.3833-10.2011 – volume: 352 start-page: 705 year: 1998 ident: B289 article-title: Treatment of Tourette's syndrome with mecamylamine publication-title: Lancet doi: 10.1016/S0140-6736(05)60822-7 – volume: 90 start-page: 23 year: 1989 ident: B304 article-title: Different forms of brain acetylcholinesterase and muscarinic binding in Parkinson's disease publication-title: J. Neurol. Sci doi: 10.1016/0022-510X(89)90042-7 – volume: 53 start-page: 1059 year: 1993 ident: B94 article-title: Ultrastructural features of the choline acetyltransferase-containing neurons and relationships with nigral dopaminergic and cortical afferent pathways in the rat striatum publication-title: Neuroscience doi: 10.1016/0306-4522(93)90489-3 – volume: 26 start-page: S2 year: 2011 ident: B116 article-title: The movement disorder society evidence-based medicine review update: treatments for the motor symptoms of Parkinson's disease publication-title: Mov. Disord. Off. J. Mov. Disord. Soc doi: 10.1002/mds.23829 – volume: 114 start-page: 475 year: 2002 ident: B163 article-title: Firing modes of midbrain dopamine cells in the freely moving rat publication-title: Neuroscience doi: 10.1016/S0306-4522(02)00267-1 – volume: 111 start-page: 103 year: 2014 ident: B183 article-title: Nicotinic receptors regulate the dynamic range of dopamine release in vivo publication-title: J. Neurophysiol doi: 10.1152/jn.00269.2013 – volume: 324 start-page: 9 year: 2002 ident: B205 article-title: Synaptic association of dopaminergic axon terminals and neurokinin-1 receptor-expressing intrinsic neurons in the striatum of the rat publication-title: Neurosci. Lett doi: 10.1016/S0304-3940(02)00138-6 – volume: 5 start-page: 318 year: 2014 ident: B245 article-title: M4 mAChR-mediated modulation of glutamatergic transmission at corticostriatal synapses publication-title: ACS Chem. Neurosci doi: 10.1021/cn500003z – volume: 162 start-page: 94 year: 2011 ident: B88 article-title: Calcium signalling mediated through α7 and non-α7 nAChR stimulation is differentially regulated in bovine chromaffin cells to induce catecholamine release publication-title: Br. J. Pharmacol doi: 10.1111/j.1476-5381.2010.01034.x – volume: 58 start-page: 312 year: 2000 ident: B174 article-title: Alpha-bungarotoxin-sensitive nicotinic receptors indirectly modulate [(3)H]dopamine release in rat striatal slices via glutamate release publication-title: Mol. Pharmacol doi: 10.1124/mol.58.2.312 – volume: 7 start-page: e33348 year: 2012 ident: B254 article-title: Dopamine D1-D2 receptor heteromer in dual phenotype GABA/glutamate-coexpressing striatal medium spiny neurons: regulation of BDNF, GAD67 and VGLUT1/2 publication-title: PLoS ONE doi: 10.1371/journal.pone.0033348 – volume: 4 start-page: 195 year: 1989 ident: B265 article-title: Effects of etybenzatropine and diazepam on levodopa-induced diphasic dyskinesias in Parkinson's disease publication-title: Mov. Disord. Off. J. Mov. Disord. Soc doi: 10.1002/mds.870040301 – volume: 10 start-page: 3020 year: 1998a ident: B51 article-title: Blockade of M2-like muscarinic receptors enhances long-term potentiation at corticostriatal synapses publication-title: Eur. J. Neurosci doi: 10.1111/j.1460-9568.1998.00348.x – volume: 113 start-page: 43 year: 1994 ident: B191 article-title: Inhibition by KF17837 of adenosine A2A receptor-mediated modulation of striatal GABA and ACh release publication-title: Br. J. Pharmacol doi: 10.1111/j.1476-5381.1994.tb16171.x – volume: 57 start-page: 521 year: 1995 ident: B230 article-title: Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons publication-title: Annu. Rev. Physiol doi: 10.1146/annurev.ph.57.030195.002513 – volume: 1 start-page: 252 year: 2009 ident: B104 article-title: Choline transporter gene variation is associated with attention-deficit hyperactivity disorder publication-title: J. Neurodev. Disord doi: 10.1007/s11689-009-9033-8 – volume: 1155 start-page: 208 year: 2007 ident: B153 article-title: Localization of Parkinson's disease-associated LRRK2 in normal and pathological human brain publication-title: Brain Res doi: 10.1016/j.brainres.2007.04.034 – volume: 29 start-page: 1253 year: 1979 ident: B203 article-title: Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy publication-title: Neurology doi: 10.1212/WNL.29.9_Part_1.1253 – volume: 82 start-page: 63 year: 2014b ident: B239 article-title: Striatal cholinergic interneurons drive GABA release from dopamine terminals publication-title: Neuron doi: 10.1016/j.neuron.2014.01.023 – volume: 128 start-page: 531 year: 1999 ident: B279 article-title: Tonically active neurons in the monkey striatum do not preferentially respond to appetitive stimuli publication-title: Exp. Brain Res doi: 10.1007/s002210050876 – volume: 19 start-page: 645 year: 2013a ident: B291 article-title: Pathological gambling in Parkinson's disease. A comprehensive review publication-title: Parkinsonism Relat. Disord doi: 10.1016/j.parkreldis.2013.02.007 – reference: 23079510 - Rev Neurosci. 2012;23(5-6):747-67 – reference: 11860453 - Eur J Neurosci. 2001 Nov;14(10):1577-89 – reference: 23483637 - Mov Disord. 2013 May;28(5):566-8 – reference: 19941350 - J Comp Neurol. 2010 Feb 1;518(3):277-91 – reference: 24434772 - Neuroscience. 2014 Mar 28;263:138-47 – reference: 1488113 - Neuroscience. 1992 Dec;51(3):533-45 – reference: 16229010 - Mov Disord. 2006 Apr;21(4):456-61 – reference: 15345659 - Br J Pharmacol. 2004 Sep;143(1):119-31 – reference: 10971630 - Eur J Neurosci. 2000 Aug;12(8):2871-80 – reference: 17553945 - J Neurophysiol. 2007 Aug;98(2):581-93 – reference: 16269435 - J Physiol. 2005 Dec 15;569(Pt 3):715-21 – reference: 12556914 - Mol Psychiatry. 2003 Jan;8(1):103-8 – reference: 2903785 - Brain Res Bull. 1988 Aug;21(2):295-304 – reference: 24528004 - ACS Chem Neurosci. 2014 Apr 16;5(4):318-24 – reference: 10858614 - Neuroscience. 2000;98(1):79-87 – reference: 7675190 - Neuroscience. 1995 Aug;67(3):609-23 – reference: 15269338 - Physiol Rev. 2004 Jul;84(3):835-67 – reference: 1976250 - Proc Natl Acad Sci U S A. 1990 Sep;87(18):7025-9 – reference: 9372294 - Exp Brain Res. 1997 Oct;116(3):456-66 – reference: 6289994 - Brain Res. 1982 Sep 23;248(1):61-9 – reference: 10942042 - Behav Brain Res. 2000 Aug;113(1-2):159-68 – reference: 2355224 - J Neurochem. 1990 Jul;55(1):31-8 – reference: 23775300 - Metab Brain Dis. 2013 Sep;28(3):501-8 – reference: 8207500 - J Neurosci. 1994 Jun;14(6):3969-84 – reference: 8756443 - J Neurosci. 1996 Aug 15;16(16):5141-53 – reference: 23722210 - Nat Methods. 2013 Jun;10(6):508-13 – reference: 17512502 - Brain Res. 2007 Jun 25;1155:208-19 – reference: 11002906 - Addiction. 2000 Aug;95 Suppl 2:S91-117 – reference: 17699666 - J Neurosci. 2007 Aug 15;27(33):8845-56 – reference: 9889300 - Brain Res Mol Brain Res. 1999 Jan 22;64(1):11-23 – reference: 1729398 - J Neurochem. 1992 Feb;58(2):529-41 – reference: 17408758 - Trends Neurosci. 2007 May;30(5):228-35 – reference: 2891799 - J Neurosci. 1987 Dec;7(12):3915-34 – reference: 9728992 - Lancet. 1998 Aug 29;352(9129):705-6 – reference: 17169479 - Prog Neurobiol. 2007 Apr;81(5-6):253-71 – reference: 7623152 - J Neurosci. 1995 Jul;15(7 Pt 2):5297-307 – reference: 6532518 - Brain Res Bull. 1984 Dec;13(6):751-84 – reference: 11301208 - Neuroscience. 2001;103(4):1017-24 – reference: 22327472 - Nat Neurosci. 2012 Feb 12;15(4):613-9 – reference: 14729237 - Neurosci Lett. 2004 Jan 23;355(1-2):69-72 – reference: 11494403 - Synapse. 2001 Sep 15;41(4):329-36 – reference: 15193758 - Neurosci Lett. 2004 May 20;362(2):79-82 – reference: 9351509 - Br J Pharmacol. 1997 Oct;122(3):520-4 – reference: 23481547 - Exp Neurol. 2013 Sep;247:582-94 – reference: 2861250 - J Neurochem. 1985 Aug;45(2):604-10 – reference: 9812108 - Am J Psychiatry. 1998 Nov;155(11):1490-501 – reference: 22229124 - Cold Spring Harb Perspect Med. 2011 Sep;1(1):a008862 – reference: 7812630 - Br J Pharmacol. 1994 Sep;113(1):43-8 – reference: 8985014 - Science. 1997 Jan 10;275(5297):213-5 – reference: 2848109 - J Neurosci. 1988 Oct;8(10):3750-6 – reference: 15271494 - Trends Neurosci. 2004 Aug;27(8):468-74 – reference: 8809795 - Neuroscience. 1996 Aug;73(3):751-60 – reference: 16738217 - J Neurophysiol. 2006 Sep;96(3):1581-91 – reference: 8429821 - Mol Pharmacol. 1993 Feb;43(2):149-57 – reference: 20439843 - Neurology. 2010 May 4;74(18):1416-23 – reference: 12151512 - J Neurosci. 2002 Aug 1;22(15):6347-52 – reference: 3039125 - J Physiol. 1986 Nov;380:593-608 – reference: 23948994 - J Parkinsons Dis. 2013 Jan 1;3(3):241-54 – reference: 1915708 - Exp Brain Res. 1991;85(3):491-500 – reference: 45482 - Arch Gen Psychiatry. 1977 Nov;34(11):1319-23 – reference: 21704718 - Neurobiol Learn Mem. 2011 Sep;96(2):95-120 – reference: 19445928 - Eur J Pharmacol. 2009 Aug 1;615(1-3):91-101 – reference: 10448421 - Exp Neurol. 1999 Jul;158(1):97-108 – reference: 11160411 - J Neurosci. 2001 Feb 15;21(4):1393-400 – reference: 20463630 - Psychiatr Genet. 2010 Dec;20(6):289-97 – reference: 22005945 - Neurol Sci. 2012 Aug;33(4):945-8 – reference: 9582229 - J Neurophysiol. 1998 May;79(5):2568-80 – reference: 2395528 - Neurosci Lett. 1990 Jul 3;114(2):154-9 – reference: 24632480 - Exp Neurol. 2014 May;255:154-60 – reference: 11044742 - Neuropharmacology. 2000 Oct;39(13):2715-25 – reference: 8106150 - Clin Neuropharmacol. 1993 Oct;16(5):418-27 – reference: 12706204 - J Chem Neuroanat. 2003 Mar;25(3):161-73 – reference: 8232601 - Naunyn Schmiedebergs Arch Pharmacol. 1993 Sep;348(3):234-41 – reference: 1542411 - Neuroscience. 1992;46(2):351-60 – reference: 23034651 - Nature. 2012 Oct 11;490(7419):262-6 – reference: 6589643 - Proc Natl Acad Sci U S A. 1984 Aug;81(15):4998-5001 – reference: 17203014 - Neuropsychopharmacology. 2007 Aug;32(8):1840-54 – reference: 8684624 - Neuroscience. 1996 Apr;71(4):937-47 – reference: 21432576 - Atten Defic Hyperact Disord. 2009 May;1(1):19-24 – reference: 17974593 - J Physiol. 2008 Jan 1;586(1):265-82 – reference: 2366 - Brain Res. 1976 Jan 30;102(1):164-73 – reference: 15525771 - J Neurosci. 2004 Nov 3;24(44):9870-7 – reference: 24613418 - Neuron. 2014 Apr 2;82(1):63-70 – reference: 11230867 - Biol Psychiatry. 2001 Feb 1;49(3):166-74 – reference: 8757038 - Neurology. 1996 Aug;47(2):557-62 – reference: 11222635 - J Neurosci. 2001 Mar 1;21(5):1452-63 – reference: 8667239 - J Pharmacol Exp Ther. 1996 Jun;277(3):1685-93 – reference: 23442092 - Eur J Neurosci. 2013 May;37(9):1470-7 – reference: 23902940 - J Pharmacol Exp Ther. 2013 Oct;347(1):225-34 – reference: 23348498 - Mol Pharmacol. 2013 Apr;83(4):746-52 – reference: 24559678 - Neuron. 2014 Feb 19;81(4):901-12 – reference: 15589697 - J Chem Neuroanat. 2005 Jan;29(1):1-11 – reference: 7884049 - J Comp Neurol. 1994 Dec 15;350(3):412-38 – reference: 9822774 - J Neurosci. 1998 Dec 1;18(23):10207-18 – reference: 4948768 - Eur J Clin Pharmacol. 1971 Dec;4(1):18-21 – reference: 23490464 - Parkinsonism Relat Disord. 2013 Jul;19(7):645-53 – reference: 3514543 - Ital J Neurol Sci. 1986 Feb;7(1):139-43 – reference: 11044737 - Neuropharmacology. 2000 Oct;39(13):2673-80 – reference: 24966377 - J Neurosci. 2014 Jun 25;34(26):8772-7 – reference: 12769615 - Curr Drug Targets CNS Neurol Disord. 2002 Aug;1(4):433-42 – reference: 18000672 - Acta Neuropathol. 2008 Apr;115(4):453-9 – reference: 1717519 - J Comp Neurol. 1991 Jul 15;309(3):391-401 – reference: 11043817 - Drugs Aging. 2000 Sep;17(3):165-81 – reference: 10212321 - J Neurosci. 1999 May 1;19(9):3629-38 – reference: 11983282 - Neurosci Lett. 2002 May 10;324(1):9-12 – reference: 19915575 - Nat Genet. 2009 Dec;41(12):1308-12 – reference: 6322011 - Nature. 1984 Mar 15-21;308(5956):278-80 – reference: 21544206 - PLoS One. 2011 Apr 22;6(4):e19155 – reference: 2779590 - Mov Disord. 1989;4(3):195-201 – reference: 6382048 - Neuroscience. 1984 Jul;12(3):711-8 – reference: 12492422 - Eur J Neurosci. 2002 Dec;16(12):2279-90 – reference: 15580606 - Mov Disord. 2005 Mar;20(3):342-4 – reference: 4733 - N Engl J Med. 1976 Jun 10;294(24):1305-9 – reference: 7783862 - Neurology. 1995 Jun;45(6):1041-51 – reference: 17631864 - Biochem Pharmacol. 2007 Oct 15;74(8):1224-34 – reference: 17173981 - Trends Neurosci. 2007 Feb;30(2):62-9 – reference: 2826189 - Eur J Pharmacol. 1987 Nov 10;143(2):195-204 – reference: 22219231 - Cleve Clin J Med. 2012 Jan;79(1):28-35 – reference: 16276355 - Nat Rev Neurosci. 2005 Oct;6(10):787-98 – reference: 22693036 - Mov Disord. 2012 Jul;27(8):947-57 – reference: 9045723 - J Neurosci. 1997 Mar 15;17(6):1940-9 – reference: 10658616 - Neuroscience. 2000;95(2):367-76 – reference: 10973600 - Brain Res. 2000 Sep 8;876(1-2):124-30 – reference: 12831856 - Neuroscience. 2003;119(4):965-77 – reference: 23242365 - Behav Neurol. 2013 Jan 1;27(4):501-13 – reference: 17446041 - J Chem Neuroanat. 2007 Jul;33(4):167-92 – reference: 14521868 - Neurobiol Learn Mem. 2003 Nov;80(3):257-67 – reference: 14643839 - Pharmacol Biochem Behav. 2003 Dec;76(3-4):409-15 – reference: 7778876 - Annu Rev Physiol. 1995;57:521-46 – reference: 9705995 - J Physiol. 1998 Jul 15;510 ( Pt 2):441-53 – reference: 22526540 - Psychopharmacology (Berl). 2012 Oct;223(3):251-8 – reference: 24948810 - J Neurosci. 2014 Jun 18;34(25):8557-69 – reference: 24633735 - J Comp Neurol. 2014 Aug 1;522(11):2465-80 – reference: 1676895 - Neuron. 1991 Jul;7(1):81-9 – reference: 11166340 - Neuropharmacology. 2001 Mar;40(3):460-3 – reference: 19623583 - J Cell Biochem. 2009 Oct 1;108(2):433-46 – reference: 8947924 - Neurochem Res. 1996 Nov;21(11):1347-51 – reference: 4157009 - Brain. 1974 Sep;97(3):457-72 – reference: 10646537 - J Neurochem. 2000 Feb;74(2):839-46 – reference: 20613723 - Nature. 2010 Jul 29;466(7306):622-6 – reference: 16876883 - Trends Pharmacol Sci. 2006 Sep;27(9):482-91 – reference: 17942622 - J Neurophysiol. 2007 Dec;98(6):3388-96 – reference: 10481007 - Science. 1999 Sep 10;285(5434):1725-8 – reference: 23640072 - Psychopharmacology (Berl). 2014 Mar;231(6):1251-65 – reference: 1941081 - J Neurosci. 1991 Oct;11(10):3218-26 – reference: 16995263 - J Physiol. 1941 Jun 30;99(4):436-42 – reference: 16546312 - Biol Psychol. 2006 Jul;73(1):19-38 – reference: 9007842 - Naunyn Schmiedebergs Arch Pharmacol. 1997 Jan;355(1):48-56 – reference: 11738031 - Neuron. 2001 Dec 6;32(5):855-65 – reference: 10410773 - Adv Neurol. 1999;80:565-74 – reference: 4278580 - Brain Res. 1974 Nov 15;80(2):355-8 – reference: 22021173 - Mov Disord. 2011 Oct;26 Suppl 3:S2-41 – reference: 9254687 - J Neurosci. 1997 Sep 1;17(17):6761-8 – reference: 11596051 - J Comp Neurol. 2001 Oct 15;439(2):235-47 – reference: 22428025 - PLoS One. 2012;7(3):e33348 – reference: 18626069 - Physiol Rev. 2008 Jul;88(3):1183-241 – reference: 6320043 - Neuroscience. 1983 Dec;10(4):1105-20 – reference: 1834312 - Brain Res. 1991 Aug 9;556(1):117-22 – reference: 8182478 - J Neurosci. 1994 May;14(5 Pt 2):3351-63 – reference: 19631006 - Expert Rev Mol Med. 2009 Jul 27;11:e22 – reference: 10598794 - Naunyn Schmiedebergs Arch Pharmacol. 1999 Nov;360(5):552-7 – reference: 8232363 - Mov Disord. 1993 Oct;8(4):512-4 – reference: 12804486 - Cochrane Database Syst Rev. 2003;(2):CD003735 – reference: 17376976 - J Neurosci. 2007 Mar 21;27(12):3148-56 – reference: 2432992 - Brain Res. 1986 Nov 12;397(2):279-89 – reference: 8417140 - J Neurochem. 1993 Jan;60(1):197-203 – reference: 18278042 - Nat Neurosci. 2008 Mar;11(3):292-300 – reference: 1651375 - J Neurosci. 1991 Aug;11(8):2332-8 – reference: 1280527 - Brain Res. 1992 Oct 30;594(2):253-62 – reference: 23296794 - J Comp Neurol. 2013 Aug 1;521(11):2502-22 – reference: 16822531 - Physiol Behav. 2006 Nov 30;89(4):531-5 – reference: 20109141 - Curr Pharm Des. 2010 Jan;16(3):309-22 – reference: 23773793 - Biol Psychiatry. 2013 Nov 15;74(10):768-76 – reference: 20371269 - Neuroscience. 2010 Jun 30;168(2):395-404 – reference: 17215400 - J Neurosci. 2007 Jan 10;27(2):391-400 – reference: 2723671 - J Neurol Sci. 1989 Mar;90(1):23-32 – reference: 8809793 - Neuroscience. 1996 Aug;73(3):715-31 – reference: 10933116 - J Child Adolesc Psychopharmacol. 2000 Summer;10(2):59-68 – reference: 6371818 - Proc Natl Acad Sci U S A. 1984 Apr;81(8):2572-6 – reference: 12470124 - Arch Gen Psychiatry. 2002 Dec;59(12):1085-96 – reference: 2964509 - J Neurochem. 1988 Apr;50(4):1111-6 – reference: 24731518 - Neurobiol Aging. 2014 Sep;35(9):2179.e1-6 – reference: 11052217 - Trends Neurosci. 2000 Oct;23(10 Suppl):S28-33 – reference: 23032073 - Neuropsychopharmacology. 2013 Feb;38(3):405-13 – reference: 9886672 - Neuropharmacology. 1998 Dec;37(12 ):1493-502 – reference: 10891862 - Synapse. 2000 Sep 15;37(4):252-61 – reference: 19071114 - Exp Neurol. 2009 Feb;215(2):388-96 – reference: 21048130 - J Neurosci. 2010 Nov 3;30(44):14719-23 – reference: 24671996 - J Neurosci. 2014 Mar 26;34(13):4509-18 – reference: 23345240 - J Neurosci. 2013 Jan 23;33(4):1678-83 – reference: 2874159 - J Comp Neurol. 1986 Jul 15;249(3):293-336 – reference: 12867509 - J Neurosci. 2003 Jul 16;23(15):6245-54 – reference: 11517238 - J Neurosci. 2001 Sep 1;21(17):6492-501 – reference: 16682554 - Arch Neurol. 2006 May;63(5):782-4 – reference: 21880943 - J Neurophysiol. 2011 Dec;106(6):3019-34 – reference: 17689498 - Biochem Pharmacol. 2007 Oct 15;74(8):1212-23 – reference: 11422455 - Eur J Neurosci. 2001 Jun;13(11):2141-7 – reference: 22840394 - Cell Rep. 2012 Jul 26;2(1):33-41 – reference: 10202545 - Annu Rev Neurosci. 1999;22:443-85 – reference: 1673074 - Br J Pharmacol. 1991 Feb;102(2):518-22 – reference: 20890450 - Front Neuroanat. 2010 Sep 14;4:null – reference: 7693897 - J Neurosci. 1993 Nov;13(11):4908-23 – reference: 23178810 - Nature. 2012 Dec 20;492(7429):452-6 – reference: 12824770 - Neuroreport. 2003 Jul 1;14(9):1253-6 – reference: 573405 - Neurology. 1979 Sep;29(9 Pt 1):1253-60 – reference: 9758172 - Eur J Neurosci. 1998 Sep;10 (9):3020-3 – reference: 18971464 - J Neurosci. 2008 Oct 29;28(44):11221-30 – reference: 1976420 - Brain Res. 1990 Jul 16;523(1):51-6 – reference: 1695404 - Trends Neurosci. 1990 Jul;13(7):281-5 – reference: 2479133 - Trends Neurosci. 1989 Oct;12(10):366-75 – reference: 1527598 - J Neurosci. 1992 Sep;12(9):3591-600 – reference: 22794260 - Neuron. 2012 Jul 12;75(1):58-64 – reference: 50112 - Brain Res. 1975 May 2;88(2):195-209 – reference: 2966886 - Life Sci. 1988;42(20):1933-9 – reference: 11044745 - Neuropharmacology. 2000 Oct;39(13):2756-69 – reference: 15019426 - Neurosci Biobehav Rev. 2004 Jan;27(8):765-76 – reference: 24659805 - J Pharmacol Exp Ther. 2014 Jun;349(3):373-82 – reference: 20166959 - Curr Top Med Chem. 2010;10(2):144-52 – reference: 2563908 - Neurosci Lett. 1989 Feb 13;97(1-2):6-10 – reference: 2243614 - Neurosci Lett. 1990 Aug 24;116(3):347-51 – reference: 9221773 - J Neurosci. 1997 Aug 1;17(15):5747-59 – reference: 2883616 - Neurosci Lett. 1987 Mar 31;75(2):205-10 – reference: 23891638 - Neuropharmacology. 2013 Dec;75:78-85 – reference: 18753369 - J Neurosci. 2008 Aug 27;28(35):8682-90 – reference: 10053 - Brain Res. 1976 Nov 12;116(3):531-7 – reference: 73064 - Lancet. 1977 Dec 3;2(8049):1157-8 – reference: 23966676 - J Neurophysiol. 2013 Nov;110(10 ):2325-36 – reference: 2687795 - Pharm Weekbl Sci. 1989 Oct 20;11(5):146-50 – reference: 17825262 - Biochem Pharmacol. 2007 Oct 15;74(8):1235-46 – reference: 21273403 - J Neurosci. 2011 Jan 26;31(4):1183-92 – reference: 11713470 - Nat Neurosci. 2001 Dec;4(12):1224-9 – reference: 12695545 - Mol Pharmacol. 2003 May;63(5):1169-79 – reference: 16093396 - J Neurosci. 2005 Aug 10;25(32):7449-58 – reference: 10908298 - Mol Pharmacol. 2000 Aug;58(2):312-8 – reference: 12859419 - Clin Exp Pharmacol Physiol. 2003 May-Jun;30(5-6):307-16 – reference: 16699510 - Nat Neurosci. 2006 Jun;9(6):832-42 – reference: 8248498 - Prog Brain Res. 1993;98:113-20 – reference: 1817734 - Brain Res. 1991 Dec 20;567(2):313-6 – reference: 10541747 - Exp Brain Res. 1999 Oct;128(4):531-4 – reference: 9585352 - Ann Neurol. 1998 May;43(5):586-97 – reference: 2303856 - J Neurosci. 1990 Feb;10(2):508-19 – reference: 9109520 - J Neurochem. 1997 May;68(5):1942-8 – reference: 20670836 - Neuron. 2010 Jul 29;67(2):294-307 – reference: 7870294 - Neuroscience. 1994 Oct;62(3):635-40 – reference: 9118315 - Mol Psychiatry. 1996 Mar;1(1):54-8 – reference: 22586376 - Front Syst Neurosci. 2012 May 04;6:33 – reference: 10770997 - Eur J Pharmacol. 2000 Mar 30;393(1-3):51-8 – reference: 6168334 - Brain Res. 1981 Sep 7;220(1):67-80 – reference: 1632582 - Ann N Y Acad Sci. 1992 Jun 28;654:171-91 – reference: 10098939 - J Comp Neurol. 1999 Mar 22;405(4):450-71 – reference: 16759874 - Neurobiol Dis. 2006 Aug;23(2):481-9 – reference: 2402490 - Proc Natl Acad Sci U S A. 1990 Sep;87(18):7050-4 – reference: 7685068 - Neuroscience. 1993 Apr;53(4):1059-71 – reference: 6150070 - J Neurosci. 1984 Nov;4(11):2866-76 – reference: 17142832 - Brain. 2007 Jan;130(Pt 1):222-32 – reference: 15146187 - Nat Neurosci. 2004 Jun;7(6):581-2 – reference: 22158514 - Nat Neurosci. 2011 Dec 11;15(1):123-30 – reference: 2572435 - Eur J Pharmacol. 1989 Aug 29;167(3):375-83 – reference: 20200117 - J Pharmacol Exp Ther. 2010 Jun;333(3):929-38 – reference: 15615835 - J Neurophysiol. 2005 May;93(5):2507-19 – reference: 10391469 - Neuroscience. 1999;91(3):891-909 – reference: 24089398 - J Neurophysiol. 2014 Jan;111(1):103-11 – reference: 18343255 - Clin Ther. 2008 Jan;30(1):182-9 – reference: 16987871 - Hum Mol Genet. 2006 Nov 1;15(21):3119-31 – reference: 12122076 - J Neurosci. 2002 Jul 15;22(14):6176-85 – reference: 17504247 - Genes Brain Behav. 2008 Feb;7(1):53-60 – reference: 8003250 - Behav Brain Res. 1994 Feb 28;60(2):211-5 – reference: 19909912 - Lancet Neurol. 2009 Dec;8(12):1140-9 – reference: 12204216 - Neuroscience. 2002;114(2):475-92 – reference: 8853955 - Crit Rev Neurobiol. 1996;10(1):69-99 – reference: 24553948 - J Neurosci. 2014 Feb 19;34(8):3090-4 – reference: 20810998 - Neurology. 2010 Oct 5;75(14):1263-9 – reference: 21241679 - Brain Res. 2011 Mar 24;1381:228-36 – reference: 11391738 - Mov Disord. 2001 May;16(3):448-58 – reference: 8878480 - Nature. 1996 Oct 24;383(6602):713-6 – reference: 10704511 - J Neurosci. 2000 Mar 15;20(6):2369-82 – reference: 19144844 - J Neurosci. 2009 Jan 14;29(2):444-53 – reference: 11569617 - Jpn J Pharmacol. 2001 Aug;86(4):429-36 – reference: 11343292 - J Comp Neurol. 2001 Jun 11;434(4):445-60 – reference: 8559249 - Nature. 1996 Feb 1;379(6564):449-51 – reference: 1992362 - Neurology. 1991 Feb;41(2 ( Pt 1)):202-5 – reference: 15706049 - Behav Neurol. 2004;15(3-4):65-71 – reference: 21969327 - Pharmacol Rev. 2011 Dec;63(4):938-66 – reference: 1672454 - Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2608-11 – reference: 20484642 - J Neurosci. 2010 May 19;30(20):6999-7016 – reference: 8182455 - J Neurosci. 1994 May;14(5 Pt 2):3005-18 – reference: 9651201 - J Neurosci. 1998 Jul 15;18(14):5180-90 – reference: 10341266 - J Neurosci. 1999 Jun 1;19(11):4682-94 – reference: 1714550 - Neuroscience. 1991;41(2-3):495-505 – reference: 12504594 - Mol Cell Neurosci. 2002 Dec;21(4):616-25 – reference: 16210393 - J Pharmacol Exp Ther. 2006 Feb;316(2):481-9 – reference: 18272687 - J Neurosci. 2008 Feb 13;28(7):1672-81 – reference: 16402096 - Br J Pharmacol. 2006 Jan;147 Suppl 1:S127-35 – reference: 19892136 - Handb Clin Neurol. 2010;95:501-46 – reference: 2428901 - J Exp Biol. 1986 Sep;124:203-24 – reference: 1376453 - Neuroscience. 1992;48(3):545-59 – reference: 15271493 - Trends Neurosci. 2004 Aug;27(8):460-7 – reference: 1638402 - Brain Res. 1992 Mar 6;574(1-2):307-11 – reference: 23856296 - Biol Psychiatry. 2014 Feb 1;75(3):207-14 – reference: 15146188 - Nat Neurosci. 2004 Jun;7(6):583-4 – reference: 2172326 - J Comp Neurol. 1990 Sep 8;299(2):187-228 – reference: 10218781 - Neuroscience. 1999 Mar;90(3):803-14 – reference: 12067226 - J Neurochem. 2002 Apr;81(1):142-9 – reference: 8987803 - J Neurosci. 1997 Jan 15;17(2):819-33 – reference: 11953457 - J Neurochem. 2002 Mar;80(6):1071-8 – reference: 2885073 - Brain Res. 1987 Jun 9;413(1):179-84 – reference: 20181592 - J Neurosci. 2010 Feb 24;30(8):2951-9 – reference: 8613722 - J Neurosci. 1995 Dec;15(12):7821-36 – reference: 21700460 - Curr Biol. 2011 Jul 12;21(13):1081-91 – reference: 8613942 - J Pharmacol Exp Ther. 1996 Apr;277(1):359-65 – reference: 7823150 - J Neurosci. 1995 Jan;15(1 Pt 1):458-69 – reference: 10613493 - Neuroscience. 1999;94(1):21-31 – reference: 18180757 - Mol Psychiatry. 2009 May;14(5):546-54 – reference: 11117745 - Nature. 2000 Nov 30;408(6812):584-8 – reference: 11082121 - Br J Pharmacol. 2000 Nov;131(6):1135-42 – reference: 23045343 - J Physiol. 2013 Jan 1;591(1):203-17 – reference: 20203199 - J Neurosci. 2010 Mar 3;30(9):3398-408 – reference: 17427940 - Mov Disord. 2007 Jul 30;22(10):1379-89; quiz 1523 – reference: 23161142 - Subcell Biochem. 2012;63:241-62 – reference: 15341594 - Eur J Neurosci. 2004 Sep;20(5):1219-30 – reference: 22516415 - Clin Neurol Neurosurg. 2012 Dec;114(10):1308-11 – reference: 21303898 - Pharmacol Rev. 2011 Mar;63(1):182-217 – reference: 15130710 - Prog Neurobiol. 2004 Feb;72(3):195-221 – reference: 21427783 - Front Syst Neurosci. 2011 Mar 03;5:11 – reference: 16326108 - Neurobiol Dis. 2006 Apr;22(1):143-52 – reference: 23841846 - Eur J Neurosci. 2013 Oct;38(7):3036-43 – reference: 9065864 - J Neurophysiol. 1997 Feb;77(2):1003-15 – reference: 7317794 - Brain Res Bull. 1981 Nov;7(5):487-507 – reference: 12832552 - J Neurosci. 2003 Jun 15;23(12):5272-82 – reference: 1309647 - Neuron. 1992 Jan;8(1):135-43 – reference: 10751429 - J Neurosci. 2000 Apr 15;20(8):2783-91 – reference: 21228905 - Front Neuroanat. 2010 Dec 29;4:150 – reference: 7569895 - Science. 1995 Sep 22;269(5231):1692-6 – reference: 21187382 - Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):840-5 – reference: 22562772 - J Pharmacol Exp Ther. 2012 Aug;342(2):335-44 – reference: 20554874 - J Neurosci. 2010 Jun 16;30(24):8229-33 – reference: 2149667 - Brain Res Bull. 1990 Dec;25(6):903-12 – reference: 19812319 - J Neurosci. 2009 Oct 7;29(40):12428-39 – reference: 10598795 - Naunyn Schmiedebergs Arch Pharmacol. 1999 Nov;360(5):558-64 – reference: 21547719 - J Neurodev Disord. 2009 Dec;1(4):252-63 – reference: 12505810 - Am J Psychiatry. 2003 Jan;160(1):118-27 – reference: 8987749 - J Neurosci. 1997 Jan 1;17(1):204-15 – reference: 10854724 - Neurosci Lett. 2000 Jun 23;287(2):109-12 – reference: 20840468 - Br J Pharmacol. 2011 Jan;162(1):94-110 – reference: 9507137 - Brain Res. 1998 Jan 12;780(2):210-7 – reference: 4155220 - Acta Neurol Scand. 1974;50(6):801-11 – reference: 20347906 - Neurochem Int. 2010 May-Jun;56(6-7):850-5 – reference: 15537735 - Learn Mem. 2004 Nov-Dec;11(6):755-60 – reference: 12388645 - J Pharmacol Exp Ther. 2002 Nov;303(2):633-9 – reference: 8495354 - Brain Res. 1993 Apr 16;608(2):198-203 – reference: 7845412 - Mov Disord. 1994 Nov;9(6):689 – reference: 8950106 - Eur J Neurosci. 1996 Nov;8(11):2428-39 – reference: 2404203 - Mov Disord. 1990;5(1):47-8 – reference: 16993030 - J Physiol. 1910 Dec 31;41(5):318-44 – reference: 16026468 - Eur J Neurosci. 2005 Jun;21(12):3301-9 – reference: 23992036 - J Neurochem. 2013 Dec;127(6):762-71 – reference: 1336019 - J Comp Neurol. 1992 Dec 8;326(2):193-216 – reference: 15649484 - Exp Neurol. 2005 Feb;191(2):292-300 – reference: 13712629 - Nature. 1961 Jan 14;189:123-5 – reference: 9334422 - J Neurosci. 1997 Nov 1;17(21):8498-505 – reference: 8263546 - J Neurochem. 1994 Jan;62(1):70-5 |
| SSID | ssj0000402003 |
| Score | 2.3653352 |
| SecondaryResourceType | review_article |
| Snippet | The striatum plays a central role in motor control and motor learning. Appropriate responses to environmental stimuli, including pursuit of reward or avoidance... |
| SourceID | doaj pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 22 |
| SubjectTerms | Acetylcholine cholinergic interneuron Neuroscience Parkinson’s disease plasticity Striatum |
| SummonAdditionalLinks | – databaseName: DOAJ Open Access Full Text dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlh9BLSNs0dZIGF3Lpwazej2MTsoRAemogNyHJEjEEb9nHIf8-Gtm77IbQXnL1A4tvRppvLM03CF1EHQzDQTeaE9dwilVjDPUNkcJL5TlLCqqR737Lm3t--yAetlp9wZmwQR54AG5CIlBarKIJOZpQo4V3LMgkmINspdSRY4O3kqmyBkNahNmwL5mzMDNJ_eIZ9E4JqGVjSnfiUJHrf4tjvj4quRV7pofoYCSN9a9hsJ_Qh9h_Rvt347b4l8y4oflGptE1LGalnK8LdVd-9oH4Rl_Ph5bz2Qi169s6dPOw6pb1eJrjCN1Pr_9c3TRjZ4QmcM5o43VyhMo2Oh091zKQ4LB3AcS72kDa5Ewy0SdFjI853giuTEwSu-i8Sq1nX9FeP-vjN1QTr7VMLugUPI95_iYhQ8qhTXLsMp2r0GSNkw2jbDh0r3iyOX0AZG1B1gKytiBboZ-bN_4Okhn_ePYSoN88B2LX5UJ2ATu6gP2fC1Tox9pwNk8O2PFwfZytFpZIqCPOi5au0PFgyM2nqGCKCyYrpHZMvDOW3Tt991gEuLNLc87FyXsM_hR9BDggHFJyhvaW81X8nnnO0p8Xl34BRez7fw priority: 102 providerName: Directory of Open Access Journals |
| Title | Striatal cholinergic interneuron regulation and circuit effects |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/25374536 https://www.proquest.com/docview/1622058328 https://pubmed.ncbi.nlm.nih.gov/PMC4204445 https://doaj.org/article/1e675807e9c2422985ba3c6f53a21027 |
| Volume | 6 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagSIhL1fJqKFRB4sIhNI7fB4SgolRI5cRKe7Nsx4ZIVRayu1L775lx0oVFK05cckhsxf7G9sx47G8IeRV1MKwOutKcuoo3taqMaXxFpfBSec6SwtvIl1_kxYx_nov57-vRE4DLna4d5pOaDVdvrn_evIMJ_xY9TtC3p6lf3iCVKUUibNBJd8m9HC3Cg3yTsZ_XZXSVajbGKndW3NJNmcJ_l9359_HJP_TR-QHZnwzJ8v0o-UNyJ_YPyf3LKVT-CKxwTMgBvSqxj_mKXxfKLm8AIiFHXw5jGnoQTOn6tgzdENbdqpxOeDwms_OPX88uqilbQhU4Z03ldXK0kW10OnquZaDB1d4FJPRqA22TM8lEnxQ1PoIOElyZmGTtovMqtZ49IXv9oo9HpKRea5lc0Cl4HmFOJyFDAkglrx2YeAU5vcXJholKHDNaXFlwKRBZm5G1iKzNyBbk9abGj5FG4x9lPyD0m3JIgJ1fLIZvdppPlkb0dGoVTQAjozFaeMeCTII5dGJVQV7eCs7ChMEoiOvjYr20VOLdYljIdEGejoLc_KoRTHHBZEHUloi32rL9pe--Z1JuGOacc_HsfzT-mDxAOFBFNvQ52VsN6_gCbJ-VP8l7BvD8NKcneXj_Ao60BlM |
| linkProvider | Scholars Portal |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Striatal+cholinergic+interneuron+regulation+and+circuit+effects&rft.jtitle=Frontiers+in+synaptic+neuroscience&rft.au=Sean+Austin+Lim&rft.au=Un+eKang&rft.au=Daniel+S+Mcgehee&rft.date=2014-10-21&rft.pub=Frontiers+Media+S.A&rft.eissn=1663-3563&rft.volume=6&rft_id=info:doi/10.3389%2Ffnsyn.2014.00022&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_1e675807e9c2422985ba3c6f53a21027 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1663-3563&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1663-3563&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1663-3563&client=summon |